Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
int-snw-6150 | tai-screen-luciferase | 6.375 | 3.15e-136 | 3.60e-07 | 2.59e-03 | 23 | 17 |
reg-snw-51164 | tai-screen-luciferase | 4.586 | 4.41e-23 | 8.78e-04 | 1.37e-03 | 6 | 4 |
int-snw-115703 | tai-screen-luciferase | 7.396 | 8.79e-193 | 1.68e-10 | 8.31e-05 | 12 | 11 |
int-snw-2821 | tai-screen-luciferase | 7.189 | 1.73e-180 | 9.22e-10 | 1.81e-04 | 17 | 15 |
int-snw-4831 | tai-screen-luciferase | 6.314 | 3.38e-133 | 5.36e-07 | 3.08e-03 | 24 | 20 |
int-snw-80198 | tai-screen-luciferase | 6.184 | 8.76e-127 | 1.24e-06 | 4.42e-03 | 25 | 20 |
int-snw-6210 | tai-screen-luciferase | 7.555 | 1.96e-202 | 4.38e-11 | 4.46e-05 | 14 | 13 |
int-snw-51741 | tai-screen-luciferase | 6.174 | 2.67e-126 | 1.32e-06 | 4.54e-03 | 24 | 19 |
int-snw-7133 | tai-screen-luciferase | 6.428 | 5.80e-139 | 2.51e-07 | 2.21e-03 | 25 | 20 |
int-snw-5706 | tai-screen-luciferase | 6.189 | 4.80e-127 | 1.20e-06 | 4.35e-03 | 25 | 21 |
int-snw-7372 | tai-screen-luciferase | 6.242 | 1.24e-129 | 8.55e-07 | 3.77e-03 | 23 | 19 |
int-snw-23433 | tai-screen-luciferase | 6.337 | 2.49e-134 | 4.62e-07 | 2.89e-03 | 10 | 7 |
int-snw-6233 | tai-screen-luciferase | 8.389 | 3.07e-257 | 1.78e-14 | 1.14e-06 | 7 | 7 |
Gene Symbol | Entrez Gene ID | Frequency | tai-screen-luciferase gene score | Best subnetwork score | Degree | List-Gonzales GI | Tai-Hits |
---|---|---|---|---|---|---|---|
MAPK8 | 5599 | 28 | -4.403 | 6.468 | 153 | - | - |
CHMP2A | 27243 | 33 | -9.037 | 7.555 | 41 | Yes | Yes |
COPA | 1314 | 48 | -9.395 | 5.672 | 340 | Yes | Yes |
PAFAH1B1 | 5048 | 18 | -2.583 | 4.586 | 55 | Yes | - |
RPS29 | 6235 | 17 | -8.386 | 6.597 | 29 | - | - |
HSF1 | 3297 | 46 | -4.179 | 5.027 | 209 | - | Yes |
ARHGAP33 | 115703 | 9 | -3.082 | 7.396 | 5 | - | - |
RPS16 | 6217 | 38 | -5.444 | 4.880 | 205 | - | - |
PSMD1 | 5707 | 16 | -3.604 | 6.408 | 113 | - | Yes |
CDC42 | 998 | 44 | -6.960 | 4.707 | 276 | Yes | Yes |
NME2 | 4831 | 24 | -3.034 | 4.325 | 53 | - | - |
RPS6 | 6194 | 44 | -5.603 | 8.046 | 217 | Yes | - |
RAN | 5901 | 38 | -3.809 | 4.325 | 258 | Yes | Yes |
RPS18 | 6222 | 10 | -3.709 | 6.428 | 169 | Yes | - |
COPB1 | 1315 | 39 | -6.221 | 9.063 | 118 | Yes | Yes |
RPS13 | 6207 | 43 | -6.589 | 7.555 | 174 | Yes | - |
PLK1 | 5347 | 14 | -3.690 | 6.189 | 217 | Yes | - |
GOPC | 57120 | 19 | 1.749 | 4.450 | 68 | - | - |
VIM | 7431 | 18 | -3.760 | 6.428 | 246 | - | - |
RPAP2 | 79871 | 15 | 3.111 | 6.375 | 49 | - | - |
RPS9 | 6203 | 45 | -7.127 | 7.555 | 140 | Yes | - |
PRIM1 | 5557 | 9 | -3.035 | 6.184 | 53 | - | - |
RPS4X | 6191 | 44 | -6.747 | 7.555 | 263 | Yes | - |
COPZ1 | 22818 | 48 | -8.301 | 9.063 | 13 | Yes | Yes |
PSMC6 | 5706 | 14 | -3.169 | 6.408 | 158 | - | - |
RPS7 | 6201 | 15 | -4.382 | 6.375 | 165 | Yes | - |
RPS27A | 6233 | 45 | -5.631 | 8.389 | 344 | Yes | - |
PSMD3 | 5709 | 22 | -3.935 | 6.408 | 201 | - | Yes |
RPS14 | 6208 | 23 | -4.803 | 7.011 | 204 | Yes | - |
SKP1 | 6500 | 26 | -3.750 | 6.413 | 203 | - | - |
SGOL1 | 151648 | 9 | -4.118 | 6.184 | 30 | Yes | - |
RPS26 | 6231 | 43 | -7.478 | 8.046 | 60 | Yes | - |
COPG1 | 22820 | 12 | -5.279 | 7.138 | 37 | Yes | Yes |
RPS8 | 6202 | 33 | -5.545 | 7.555 | 234 | - | - |
RPS20 | 6224 | 22 | -4.757 | 6.314 | 153 | Yes | - |
RPS15 | 6209 | 30 | -5.040 | 7.011 | 116 | Yes | - |
CDC42EP2 | 10435 | 6 | -2.649 | 6.337 | 5 | - | - |
RNF20 | 56254 | 28 | -4.564 | 6.174 | 18 | - | - |
PLA2G12A | 81579 | 10 | 2.326 | 6.242 | 9 | - | - |
SRC | 6714 | 28 | -2.806 | 6.174 | 419 | Yes | - |
COPB2 | 9276 | 48 | -13.168 | 9.063 | 41 | Yes | Yes |
CKAP5 | 9793 | 46 | -7.214 | 5.672 | 130 | Yes | Yes |
ATG4C | 84938 | 10 | 2.130 | 6.242 | 321 | - | - |
RB1 | 5925 | 21 | -2.085 | 4.707 | 351 | - | - |
RPS11 | 6205 | 44 | -6.588 | 7.555 | 175 | Yes | - |
DCTN4 | 51164 | 13 | -1.882 | 4.586 | 19 | - | - |
YBX1 | 4904 | 24 | -3.033 | 5.516 | 296 | - | - |
MAP3K14 | 9020 | 15 | -3.462 | 6.375 | 138 | - | Yes |
UBB | 7314 | 30 | -4.289 | 6.428 | 147 | - | - |
RPS23 | 6228 | 21 | -4.485 | 6.375 | 118 | Yes | - |
SERBP1 | 26135 | 35 | -4.612 | 5.516 | 106 | - | Yes |
RHOQ | 23433 | 6 | 1.414 | 6.337 | 19 | - | - |
RPS24 | 6229 | 46 | -7.034 | 8.389 | 217 | Yes | - |
TUBA1C | 84790 | 10 | -4.660 | 6.242 | 91 | - | Yes |
TCERG1 | 10915 | 28 | -3.808 | 6.174 | 58 | Yes | - |
RPS3A | 6189 | 19 | -4.647 | 7.189 | 166 | Yes | - |
TNFRSF1B | 7133 | 10 | -3.319 | 6.428 | 109 | - | - |
ATP6V1D | 51382 | 30 | -4.131 | 7.286 | 149 | - | - |
RPS15A | 6210 | 36 | -5.413 | 7.555 | 177 | Yes | - |
RAD51 | 5888 | 9 | 2.995 | 6.184 | 189 | Yes | - |
MUS81 | 80198 | 9 | -2.516 | 6.184 | 66 | - | - |
WWOX | 51741 | 28 | -2.448 | 6.174 | 38 | - | - |
RPS19 | 6223 | 21 | -4.701 | 4.752 | 102 | Yes | - |
UMPS | 7372 | 10 | 1.909 | 6.242 | 18 | - | - |
GPI | 2821 | 10 | -4.130 | 7.189 | 57 | - | - |
NFKBIB | 4793 | 28 | -3.978 | 6.174 | 78 | - | - |
ARCN1 | 372 | 48 | -8.232 | 9.063 | 118 | Yes | Yes |
MRPL23 | 6150 | 15 | -2.571 | 6.375 | 9 | - | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
CDC42 | 998 | RPS27A | 6233 | pp | -- | int.I2D: SOURAV_MAPK_HIGH |
RPS20 | 6224 | RPS26 | 6231 | pp | -- | int.I2D: YeastLow |
RPS4X | 6191 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS27A | 6233 | SKP1 | 6500 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
YBX1 | 4904 | RPS23 | 6228 | pp | -- | int.Intact: MI:0914(association) |
NME2 | 4831 | RPS19 | 6223 | pp | -- | int.Proteinpedia: Mass spectrometry |
TUBA1C | 84790 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
ARCN1 | 372 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, Tarassov_PCA, YeastMedium, INTEROLOG |
RPS3A | 6189 | RPS18 | 6222 | pp | -- | int.I2D: YeastLow |
RPS20 | 6224 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
RPS13 | 6207 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BCI, HPRD, IntAct, MINT; int.Mint: MI:0915(physical association); int.HPRD: in vitro |
COPZ1 | 22818 | COPG1 | 22820 | pp | -- | int.I2D: BioGrid, HPRD, BIND; int.HPRD: in vitro, in vivo, yeast 2-hybrid; int.DIP: MI:0915(physical association) |
VIM | 7431 | SERBP1 | 26135 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, HPRD, BioGrid, MINT, StelzlHigh; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
RPS11 | 6205 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
RPS11 | 6205 | RPS19 | 6223 | pp | -- | int.I2D: IntAct_Yeast |
RPS7 | 6201 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
RPS18 | 6222 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS11 | 6205 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
RB1 | 5925 | TNFRSF1B | 7133 | pd | > | reg.pazar.txt: no annot |
COPA | 1314 | RB1 | 5925 | pd | <> | reg.ITFP.txt: no annot |
TCERG1 | 10915 | WWOX | 51741 | pp | -- | int.I2D: BioGrid, MINT, Pawson1; int.Mint: MI:0915(physical association) |
RPS3A | 6189 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS11 | 6205 | RPS18 | 6222 | pp | -- | int.I2D: YeastMedium, BioGrid_Yeast |
RPS13 | 6207 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD1 | 5707 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, Krogan_Core |
COPA | 1314 | DCTN4 | 51164 | pd | > | reg.ITFP.txt: no annot |
RPS23 | 6228 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
PLK1 | 5347 | PSMC6 | 5706 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
YBX1 | 4904 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS3A | 6189 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
RPS11 | 6205 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD1 | 5707 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
SRC | 6714 | CKAP5 | 9793 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
YBX1 | 4904 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
RPS15 | 6209 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
RPS6 | 6194 | RPS26 | 6231 | pp | -- | int.I2D: YeastLow |
COPB2 | 9276 | COPG1 | 22820 | pp | -- | int.I2D: BioGrid |
YBX1 | 4904 | RPS7 | 6201 | pp | -- | int.Intact: MI:0914(association) |
ARCN1 | 372 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
RPS15 | 6209 | RPS23 | 6228 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
RPS7 | 6201 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
RB1 | 5925 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
YBX1 | 4904 | RPS11 | 6205 | pp | -- | int.Intact: MI:0914(association) |
RPS14 | 6208 | RPS20 | 6224 | pp | -- | int.I2D: INTEROLOG, YeastMedium, BioGrid_Yeast |
CDC42 | 998 | UBB | 7314 | pp | -- | int.I2D: SOURAV_MAPK_HIGH |
NFKBIB | 4793 | UBB | 7314 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
COPB1 | 1315 | RHOQ | 23433 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vivo |
CDC42EP2 | 10435 | RHOQ | 23433 | pp | -- | int.I2D: BioGrid, HPRD, BIND; int.HPRD: in vitro, yeast 2-hybrid |
RPS15 | 6209 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS9 | 6203 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
RPS8 | 6202 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
YBX1 | 4904 | SERBP1 | 26135 | pd | > | reg.ITFP.txt: no annot |
RPS9 | 6203 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS20 | 6224 | RPS23 | 6228 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
NME2 | 4831 | RPS16 | 6217 | pp | -- | int.Proteinpedia: Mass spectrometry |
RPS8 | 6202 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS16 | 6217 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
RB1 | 5925 | SERBP1 | 26135 | pd | > | reg.pazar.txt: no annot |
RPS9 | 6203 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
SKP1 | 6500 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
RPS6 | 6194 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
PLK1 | 5347 | SGOL1 | 151648 | pp | -- | int.I2D: BioGrid |
RPS13 | 6207 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS15 | 6209 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
YBX1 | 4904 | RPS4X | 6191 | pp | -- | int.Intact: MI:0914(association) |
YBX1 | 4904 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
TNFRSF1B | 7133 | UBB | 7314 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
RPS11 | 6205 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
GPI | 2821 | RPS13 | 6207 | pp | -- | int.I2D: IntAct_Yeast |
RPS6 | 6194 | RPS23 | 6228 | pp | -- | int.I2D: YeastLow, BioGrid_Yeast |
ARCN1 | 372 | COPG1 | 22820 | pp | -- | int.I2D: HPRD; int.HPRD: in vivo |
RPS24 | 6229 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
RPS4X | 6191 | RPS7 | 6201 | pp | -- | int.I2D: BioGrid_Yeast |
RPS9 | 6203 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
RPS15A | 6210 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
RAN | 5901 | RPS11 | 6205 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, MINT_Worm, NON_CORE |
RPS7 | 6201 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
RPS7 | 6201 | RPS9 | 6203 | pp | -- | int.I2D: BioGrid_Yeast |
GPI | 2821 | RPS27A | 6233 | pp | -- | int.I2D: Krogan_NonCore |
RPS3A | 6189 | RPS23 | 6228 | pp | -- | int.I2D: BioGrid_Yeast |
COPG1 | 22820 | RHOQ | 23433 | pp | -- | int.I2D: HPRD; int.HPRD: in vivo |
RPS18 | 6222 | RPS20 | 6224 | pp | -- | int.I2D: YeastMedium, INTEROLOG, YeastHigh |
RPS3A | 6189 | RPS9 | 6203 | pp | -- | int.I2D: IntAct |
PLK1 | 5347 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
RPS9 | 6203 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS18 | 6222 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | RPS9 | 6203 | pp | -- | int.I2D: BioGrid_Yeast |
RPS8 | 6202 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS15A | 6210 | RPS18 | 6222 | pp | -- | int.I2D: YeastLow |
UBB | 7314 | WWOX | 51741 | pp | -- | int.I2D: BCI, HPRD; int.HPRD: in vivo |
PAFAH1B1 | 5048 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
PAFAH1B1 | 5048 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
RPS29 | 6235 | UMPS | 7372 | pp | -- | int.Intact: MI:0915(physical association) |
RPS27A | 6233 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
UBB | 7314 | RNF20 | 56254 | pp | -- | int.Intact: MI:0220(ubiquitination reaction); int.I2D: IntAct |
RPS8 | 6202 | SKP1 | 6500 | pp | -- | int.I2D: BioGrid_Yeast |
COPB1 | 1315 | COPG1 | 22820 | pp | -- | int.I2D: BioGrid, HPRD; int.HPRD: in vitro, in vivo, yeast 2-hybrid; int.DIP: MI:0915(physical association) |
RPS15A | 6210 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS11 | 6205 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RAD51 | 5888 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS3A | 6189 | RPS7 | 6201 | pp | -- | int.I2D: BioGrid_Yeast |
RPS11 | 6205 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
RPS3A | 6189 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
YBX1 | 4904 | SKP1 | 6500 | pp | -- | int.I2D: MINT; int.Mint: MI:0915(physical association) |
RPS18 | 6222 | RPS23 | 6228 | pp | -- | int.I2D: YeastLow |
RPS4X | 6191 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
UMPS | 7372 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
CDC42 | 998 | ARHGAP33 | 115703 | pp | -- | int.I2D: MGI |
RPS15 | 6209 | RPS18 | 6222 | pp | -- | int.I2D: INTEROLOG, YeastMedium, Yu_GoldStd |
RPS8 | 6202 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
SRC | 6714 | WWOX | 51741 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
RPS16 | 6217 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RHOQ | 23433 | GOPC | 57120 | pp | -- | int.I2D: BioGrid, HPRD; int.HPRD: in vitro, in vivo, yeast 2-hybrid |
RPS7 | 6201 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC6 | 5706 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS15A | 6210 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastHigh, YeastMedium |
RPS6 | 6194 | RPS18 | 6222 | pp | -- | int.I2D: YeastLow |
YBX1 | 4904 | RPS8 | 6202 | pp | -- | int.Intact: MI:0914(association) |
RPS13 | 6207 | RPS19 | 6223 | pp | -- | int.I2D: IntAct_Yeast |
GPI | 2821 | RPS3A | 6189 | pp | -- | int.I2D: IntAct_Yeast |
RPS20 | 6224 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
RPS9 | 6203 | RPS18 | 6222 | pp | -- | int.I2D: IntAct |
RPS4X | 6191 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS7 | 6201 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS20 | 6224 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS27A | 6233 | UBB | 7314 | pp | -- | int.I2D: BIND |
RPS4X | 6191 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
NME2 | 4831 | VIM | 7431 | pp | -- | int.HPRD: in vivo |
RAN | 5901 | RPS15 | 6209 | pp | -- | int.I2D: YeastLow |
UMPS | 7372 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS4X | 6191 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium, INTEROLOG |
RPS8 | 6202 | RPS9 | 6203 | pp | -- | int.I2D: BioGrid_Yeast |
PRIM1 | 5557 | RAD51 | 5888 | pp | -- | int.I2D: BioGrid_Yeast |
TNFRSF1B | 7133 | VIM | 7431 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
RPS3A | 6189 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
RPS8 | 6202 | RPS19 | 6223 | pp | -- | int.I2D: MINT |
RPS6 | 6194 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS13 | 6207 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
RPS8 | 6202 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
RPS3A | 6189 | RPS4X | 6191 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | COPB1 | 1315 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct_Yeast, MINT_Yeast, Krogan_Core, YeastHigh |
PSMC6 | 5706 | SKP1 | 6500 | pp | -- | int.I2D: YeastLow |
RPS8 | 6202 | CHMP2A | 27243 | pp | -- | int.I2D: BioGrid_Yeast |
RPS24 | 6229 | ATP6V1D | 51382 | pp | -- | int.I2D: BioGrid_Yeast |
RPS7 | 6201 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
RPS7 | 6201 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS13 | 6207 | RPS18 | 6222 | pp | -- | int.I2D: BioGrid_Yeast |
CDC42 | 998 | CDC42EP2 | 10435 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, HPRD, BIND, IntAct, SOURAV_MAPK_HIGH; int.HPRD: in vitro, in vivo |
PRIM1 | 5557 | MUS81 | 80198 | pp | -- | int.I2D: BioGrid_Yeast |
PLK1 | 5347 | MUS81 | 80198 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastLow |
YBX1 | 4904 | MRPL23 | 6150 | pd | <> | reg.ITFP.txt: no annot |
YBX1 | 4904 | MRPL23 | 6150 | pp | -- | int.Intact: MI:0914(association) |
PAFAH1B1 | 5048 | DCTN4 | 51164 | pd | > | reg.ITFP.txt: no annot |
RPS3A | 6189 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
RPS7 | 6201 | RPS18 | 6222 | pp | -- | int.I2D: BioGrid_Yeast |
RPS3A | 6189 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS23 | 6228 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
PLK1 | 5347 | PSMD1 | 5707 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
YBX1 | 4904 | RPS24 | 6229 | pp | -- | int.Intact: MI:0914(association) |
RPS16 | 6217 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
HSF1 | 3297 | MAPK8 | 5599 | pp | -- | int.I2D: HPRD, INNATEDB; int.HPRD: in vitro, in vivo |
RPS3A | 6189 | RPS8 | 6202 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
COPA | 1314 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastMedium |
NFKBIB | 4793 | SKP1 | 6500 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vitro |
RPS6 | 6194 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC6 | 5706 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
CDC42 | 998 | GOPC | 57120 | pp | -- | int.I2D: BioGrid |
RPS3A | 6189 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC6 | 5706 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastHigh |
COPA | 1314 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vivo |
COPB1 | 1315 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastMedium; int.DIP: MI:0915(physical association) |
RPS27A | 6233 | MUS81 | 80198 | pp | -- | int.I2D: IntAct_Yeast, YeastLow |
PLK1 | 5347 | RPS8 | 6202 | pp | -- | int.I2D: BioGrid_Fly, FlyEmbryo, IntAct_Fly |
RPS18 | 6222 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS4X | 6191 | RPS18 | 6222 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
RPS15 | 6209 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
RPS11 | 6205 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BCI, HPRD, IntAct, MINT; int.Mint: MI:0915(physical association); int.HPRD: in vitro |
RPS3A | 6189 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
VIM | 7431 | GOPC | 57120 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, HPRD, IntAct, MINT, VidalHuman_core; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
RPS4X | 6191 | RPS8 | 6202 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | TNFRSF1B | 7133 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: MINT, IntAct; int.Mint: MI:0915(physical association) |
SKP1 | 6500 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS4X | 6191 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
RPS15A | 6210 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS18 | 6222 | TNFRSF1B | 7133 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: MINT, IntAct; int.Mint: MI:0915(physical association) |
RPS13 | 6207 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
RPS13 | 6207 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RB1 | 5925 | DCTN4 | 51164 | pd | > | reg.ITFP.txt: no annot |
COPA | 1314 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
RPS4X | 6191 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
RPS11 | 6205 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD3 | 5709 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS24 | 6229 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
COPB1 | 1315 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid |
YBX1 | 4904 | RPAP2 | 79871 | pp | -- | int.I2D: BioGrid |
ARCN1 | 372 | COPB1 | 1315 | pp | -- | int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastHigh, BIND, BIND_Yeast, HPRD, Krogan_Core, MIPS; int.HPRD: in vivo |
RPS9 | 6203 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS15 | 6209 | RPS15A | 6210 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
RPS16 | 6217 | TNFRSF1B | 7133 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: MINT, IntAct; int.Mint: MI:0915(physical association) |
RPS6 | 6194 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
ARCN1 | 372 | RPS3A | 6189 | pp | -- | int.I2D: IntAct_Yeast |
PSMC6 | 5706 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
RPS16 | 6217 | RPS23 | 6228 | pp | -- | int.I2D: BioGrid_Yeast |
RB1 | 5925 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
RPS6 | 6194 | RPS20 | 6224 | pp | -- | int.I2D: YeastLow |
RPS6 | 6194 | RPS7 | 6201 | pp | -- | int.I2D: BioGrid_Yeast |
RAD51 | 5888 | VIM | 7431 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, BioGrid, HPRD, MINT, StelzlHigh; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
ARCN1 | 372 | COPA | 1314 | pp | -- | int.I2D: BCI, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh, HPRD, Krogan_Core; int.HPRD: in vivo |
GPI | 2821 | SKP1 | 6500 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC6 | 5706 | PSMD1 | 5707 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, BioGrid_Yeast, Krogan_Core, MINT_Yeast |
CDC42 | 998 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
RPS6 | 6194 | RPS8 | 6202 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
RPS4X | 6191 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast |
YBX1 | 4904 | RPS29 | 6235 | pp | -- | int.Intact: MI:0914(association) |
RPS18 | 6222 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
COPA | 1314 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
MAPK8 | 5599 | WWOX | 51741 | pp | -- | int.I2D: MINT, HPRD; int.Mint: MI:0915(physical association); int.HPRD: in vivo, yeast 2-hybrid |
RPS8 | 6202 | RPS15A | 6210 | pp | -- | int.I2D: BioGrid_Yeast |
COPB1 | 1315 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS7 | 6201 | RPS8 | 6202 | pp | -- | int.I2D: BioGrid_Yeast |
RPS18 | 6222 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
RPS23 | 6228 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
RPS16 | 6217 | RPS26 | 6231 | pp | -- | int.I2D: BioGrid_Yeast |
RAN | 5901 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
COPB1 | 1315 | TNFRSF1B | 7133 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: MINT, IntAct; int.Mint: MI:0915(physical association) |
RAD51 | 5888 | MUS81 | 80198 | pp | -- | int.I2D: BioGrid_Yeast |
RPS15A | 6210 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
ARCN1 | 372 | COPB2 | 9276 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vivo |
RAN | 5901 | SKP1 | 6500 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS8 | 6202 | MAP3K14 | 9020 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT; int.Mint: MI:0915(physical association) |
VIM | 7431 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS11 | 6205 | RPS20 | 6224 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
RPS7 | 6201 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC6 | 5706 | ATP6V1D | 51382 | pp | -- | int.I2D: YeastLow |
RPS13 | 6207 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
RPS24 | 6229 | RPS27A | 6233 | pp | -- | int.I2D: YeastMedium |
RPS8 | 6202 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS3A | 6189 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
COPA | 1314 | PAFAH1B1 | 5048 | pd | <> | reg.ITFP.txt: no annot |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0022627 | cytosolic small ribosomal subunit | 7.34e-39 | 1.20e-34 | 6.944 | 20 | 21 | 39 |
GO:0019058 | viral life cycle | 1.92e-33 | 3.13e-29 | 5.585 | 23 | 25 | 115 |
GO:0019083 | viral transcription | 4.44e-31 | 7.25e-27 | 5.889 | 20 | 22 | 81 |
GO:0006415 | translational termination | 2.21e-30 | 3.61e-26 | 5.786 | 20 | 22 | 87 |
GO:0006414 | translational elongation | 9.73e-30 | 1.59e-25 | 5.690 | 20 | 22 | 93 |
GO:0005829 | cytosol | 1.04e-28 | 1.71e-24 | 2.284 | 52 | 74 | 2562 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.13e-28 | 1.85e-24 | 5.528 | 20 | 22 | 104 |
GO:0016032 | viral process | 3.86e-28 | 6.30e-24 | 3.784 | 31 | 37 | 540 |
GO:0016071 | mRNA metabolic process | 4.52e-28 | 7.37e-24 | 4.691 | 24 | 29 | 223 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 8.29e-28 | 1.35e-23 | 5.396 | 20 | 22 | 114 |
GO:0003735 | structural constituent of ribosome | 1.32e-27 | 2.15e-23 | 5.160 | 21 | 24 | 141 |
GO:0016070 | RNA metabolic process | 5.61e-27 | 9.16e-23 | 4.544 | 24 | 29 | 247 |
GO:0006413 | translational initiation | 1.62e-26 | 2.65e-22 | 5.195 | 20 | 27 | 131 |
GO:0006412 | translation | 8.84e-23 | 1.44e-18 | 4.423 | 21 | 29 | 235 |
GO:0010467 | gene expression | 4.56e-19 | 7.44e-15 | 3.222 | 26 | 36 | 669 |
GO:0016020 | membrane | 6.17e-17 | 1.01e-12 | 2.266 | 35 | 48 | 1746 |
GO:0044267 | cellular protein metabolic process | 4.33e-16 | 7.07e-12 | 3.348 | 21 | 29 | 495 |
GO:0015935 | small ribosomal subunit | 1.40e-15 | 2.28e-11 | 6.820 | 8 | 9 | 17 |
GO:0005925 | focal adhesion | 1.77e-12 | 2.89e-08 | 3.376 | 16 | 23 | 370 |
GO:0044822 | poly(A) RNA binding | 3.36e-12 | 5.48e-08 | 2.418 | 24 | 42 | 1078 |
GO:0042274 | ribosomal small subunit biogenesis | 3.78e-12 | 6.17e-08 | 6.907 | 6 | 6 | 12 |
GO:0048205 | COPI coating of Golgi vesicle | 7.00e-12 | 1.14e-07 | 6.792 | 6 | 6 | 13 |
GO:0030126 | COPI vesicle coat | 7.00e-12 | 1.14e-07 | 6.792 | 6 | 6 | 13 |
GO:0070062 | extracellular vesicular exosome | 2.52e-11 | 4.11e-07 | 1.698 | 34 | 51 | 2516 |
GO:0005840 | ribosome | 1.11e-10 | 1.82e-06 | 5.024 | 8 | 10 | 59 |
GO:0061024 | membrane organization | 4.49e-10 | 7.33e-06 | 4.039 | 10 | 11 | 146 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 6.95e-10 | 1.13e-05 | 5.848 | 6 | 6 | 25 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.14e-08 | 1.86e-04 | 3.848 | 9 | 11 | 150 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.55e-08 | 2.52e-04 | 4.585 | 7 | 8 | 70 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.29e-08 | 3.74e-04 | 4.505 | 7 | 8 | 74 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.63e-08 | 5.93e-04 | 4.411 | 7 | 8 | 79 |
GO:0000278 | mitotic cell cycle | 7.96e-08 | 1.30e-03 | 2.855 | 12 | 16 | 398 |
GO:0005515 | protein binding | 4.46e-07 | 7.28e-03 | 0.850 | 46 | 87 | 6127 |
GO:0030529 | ribonucleoprotein complex | 4.60e-07 | 7.50e-03 | 3.881 | 7 | 8 | 114 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 6.88e-07 | 1.12e-02 | 7.170 | 3 | 3 | 5 |
GO:0005737 | cytoplasm | 1.25e-06 | 2.05e-02 | 1.079 | 35 | 65 | 3976 |
GO:0043066 | negative regulation of apoptotic process | 1.59e-06 | 2.59e-02 | 2.608 | 11 | 14 | 433 |
GO:0000028 | ribosomal small subunit assembly | 2.39e-06 | 3.90e-02 | 6.685 | 3 | 3 | 7 |
GO:0006364 | rRNA processing | 2.89e-06 | 4.71e-02 | 3.907 | 6 | 8 | 96 |
GO:0019843 | rRNA binding | 4.50e-06 | 7.34e-02 | 5.152 | 4 | 4 | 27 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 7.36e-06 | 1.20e-01 | 4.207 | 5 | 6 | 65 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.36e-06 | 1.20e-01 | 4.207 | 5 | 6 | 65 |
GO:0000209 | protein polyubiquitination | 8.65e-06 | 1.41e-01 | 3.634 | 6 | 7 | 116 |
GO:0005730 | nucleolus | 1.05e-05 | 1.72e-01 | 1.511 | 20 | 36 | 1684 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 1.30e-05 | 2.13e-01 | 4.039 | 5 | 6 | 73 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.69e-05 | 2.76e-01 | 3.962 | 5 | 6 | 77 |
GO:0000086 | G2/M transition of mitotic cell cycle | 2.24e-05 | 3.65e-01 | 3.394 | 6 | 6 | 137 |
GO:0042176 | regulation of protein catabolic process | 3.73e-05 | 6.08e-01 | 5.492 | 3 | 4 | 16 |
GO:0042981 | regulation of apoptotic process | 3.87e-05 | 6.32e-01 | 3.254 | 6 | 7 | 151 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.46e-05 | 7.27e-01 | 3.674 | 5 | 7 | 94 |
GO:0075733 | intracellular transport of virus | 4.51e-05 | 7.36e-01 | 5.404 | 3 | 3 | 17 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 4.51e-05 | 7.36e-01 | 5.404 | 3 | 3 | 17 |
GO:0022624 | proteasome accessory complex | 4.51e-05 | 7.36e-01 | 5.404 | 3 | 4 | 17 |
GO:0051683 | establishment of Golgi localization | 5.12e-05 | 8.35e-01 | 7.322 | 2 | 2 | 3 |
GO:0000056 | ribosomal small subunit export from nucleus | 5.12e-05 | 8.35e-01 | 7.322 | 2 | 2 | 3 |
GO:0006886 | intracellular protein transport | 8.26e-05 | 1.00e+00 | 3.057 | 6 | 6 | 173 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.01e-04 | 1.00e+00 | 5.033 | 3 | 5 | 22 |
GO:0030490 | maturation of SSU-rRNA | 1.02e-04 | 1.00e+00 | 6.907 | 2 | 2 | 4 |
GO:0072384 | organelle transport along microtubule | 1.02e-04 | 1.00e+00 | 6.907 | 2 | 2 | 4 |
GO:0005654 | nucleoplasm | 1.39e-04 | 1.00e+00 | 1.618 | 14 | 26 | 1095 |
GO:0034146 | toll-like receptor 5 signaling pathway | 1.54e-04 | 1.00e+00 | 3.885 | 4 | 5 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 1.54e-04 | 1.00e+00 | 3.885 | 4 | 5 | 65 |
GO:0033119 | negative regulation of RNA splicing | 1.70e-04 | 1.00e+00 | 6.585 | 2 | 2 | 5 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 2.17e-04 | 1.00e+00 | 3.757 | 4 | 5 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 2.17e-04 | 1.00e+00 | 3.757 | 4 | 5 | 71 |
GO:0034162 | toll-like receptor 9 signaling pathway | 2.29e-04 | 1.00e+00 | 3.737 | 4 | 5 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 2.42e-04 | 1.00e+00 | 3.717 | 4 | 5 | 73 |
GO:0045182 | translation regulator activity | 2.54e-04 | 1.00e+00 | 6.322 | 2 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 2.54e-04 | 1.00e+00 | 6.322 | 2 | 2 | 6 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 2.82e-04 | 1.00e+00 | 3.659 | 4 | 5 | 76 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 3.12e-04 | 1.00e+00 | 3.622 | 4 | 5 | 78 |
GO:0051219 | phosphoprotein binding | 3.15e-04 | 1.00e+00 | 4.492 | 3 | 4 | 32 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 3.43e-04 | 1.00e+00 | 3.585 | 4 | 5 | 80 |
GO:0034138 | toll-like receptor 3 signaling pathway | 3.43e-04 | 1.00e+00 | 3.585 | 4 | 5 | 80 |
GO:0007097 | nuclear migration | 3.54e-04 | 1.00e+00 | 6.100 | 2 | 2 | 7 |
GO:0007067 | mitotic nuclear division | 3.97e-04 | 1.00e+00 | 2.640 | 6 | 7 | 231 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 4.48e-04 | 1.00e+00 | 4.322 | 3 | 3 | 36 |
GO:0005813 | centrosome | 5.13e-04 | 1.00e+00 | 2.309 | 7 | 9 | 339 |
GO:0005198 | structural molecule activity | 5.24e-04 | 1.00e+00 | 2.916 | 5 | 5 | 159 |
GO:0043005 | neuron projection | 5.54e-04 | 1.00e+00 | 2.898 | 5 | 6 | 161 |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 6.58e-04 | 1.00e+00 | 4.134 | 3 | 4 | 41 |
GO:0003723 | RNA binding | 6.74e-04 | 1.00e+00 | 2.243 | 7 | 10 | 355 |
GO:0034142 | toll-like receptor 4 signaling pathway | 6.86e-04 | 1.00e+00 | 3.322 | 4 | 5 | 96 |
GO:0031274 | positive regulation of pseudopodium assembly | 7.53e-04 | 1.00e+00 | 5.585 | 2 | 2 | 10 |
GO:0005634 | nucleus | 7.54e-04 | 1.00e+00 | 0.714 | 33 | 66 | 4828 |
GO:0002224 | toll-like receptor signaling pathway | 1.10e-03 | 1.00e+00 | 3.139 | 4 | 5 | 109 |
GO:0005838 | proteasome regulatory particle | 1.10e-03 | 1.00e+00 | 5.322 | 2 | 3 | 12 |
GO:0019082 | viral protein processing | 1.10e-03 | 1.00e+00 | 5.322 | 2 | 2 | 12 |
GO:0006521 | regulation of cellular amino acid metabolic process | 1.18e-03 | 1.00e+00 | 3.848 | 3 | 5 | 50 |
GO:0007254 | JNK cascade | 1.25e-03 | 1.00e+00 | 3.820 | 3 | 3 | 51 |
GO:0032479 | regulation of type I interferon production | 1.30e-03 | 1.00e+00 | 5.207 | 2 | 2 | 13 |
GO:0071398 | cellular response to fatty acid | 1.30e-03 | 1.00e+00 | 5.207 | 2 | 2 | 13 |
GO:0030234 | enzyme regulator activity | 1.30e-03 | 1.00e+00 | 5.207 | 2 | 2 | 13 |
GO:0051403 | stress-activated MAPK cascade | 1.47e-03 | 1.00e+00 | 3.737 | 3 | 4 | 54 |
GO:0051233 | spindle midzone | 1.73e-03 | 1.00e+00 | 5.000 | 2 | 2 | 15 |
GO:0000502 | proteasome complex | 1.81e-03 | 1.00e+00 | 3.634 | 3 | 4 | 58 |
GO:0016197 | endosomal transport | 1.81e-03 | 1.00e+00 | 3.634 | 3 | 3 | 58 |
GO:0032481 | positive regulation of type I interferon production | 2.09e-03 | 1.00e+00 | 3.561 | 3 | 3 | 61 |
GO:0019068 | virion assembly | 2.23e-03 | 1.00e+00 | 4.820 | 2 | 2 | 17 |
GO:0000776 | kinetochore | 2.30e-03 | 1.00e+00 | 3.515 | 3 | 3 | 63 |
GO:0031295 | T cell costimulation | 2.74e-03 | 1.00e+00 | 3.426 | 3 | 3 | 67 |
GO:0003697 | single-stranded DNA binding | 2.98e-03 | 1.00e+00 | 3.383 | 3 | 4 | 69 |
GO:0018105 | peptidyl-serine phosphorylation | 2.98e-03 | 1.00e+00 | 3.383 | 3 | 5 | 69 |
GO:0043393 | regulation of protein binding | 3.10e-03 | 1.00e+00 | 4.585 | 2 | 2 | 20 |
GO:0003713 | transcription coactivator activity | 3.18e-03 | 1.00e+00 | 2.328 | 5 | 6 | 239 |
GO:0007220 | Notch receptor processing | 3.74e-03 | 1.00e+00 | 4.448 | 2 | 2 | 22 |
GO:0051297 | centrosome organization | 4.09e-03 | 1.00e+00 | 4.383 | 2 | 2 | 23 |
GO:2001286 | regulation of caveolin-mediated endocytosis | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0000235 | astral microtubule | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0071393 | cellular response to progesterone stimulus | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0004347 | glucose-6-phosphate isomerase activity | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0004588 | orotate phosphoribosyltransferase activity | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0004590 | orotidine-5'-phosphate decarboxylase activity | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0019242 | methylglyoxal biosynthetic process | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0033176 | proton-transporting V-type ATPase complex | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0090230 | regulation of centromere complex assembly | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0004673 | protein histidine kinase activity | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0032427 | GBD domain binding | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0022605 | oogenesis stage | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0043004 | cytoplasmic sequestering of CFTR protein | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0018106 | peptidyl-histidine phosphorylation | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0021691 | cerebellar Purkinje cell layer maturation | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0051660 | establishment of centrosome localization | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0016866 | intramolecular transferase activity | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0046469 | platelet activating factor metabolic process | 4.17e-03 | 1.00e+00 | 7.907 | 1 | 1 | 1 |
GO:0071222 | cellular response to lipopolysaccharide | 4.68e-03 | 1.00e+00 | 3.152 | 3 | 4 | 81 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 4.82e-03 | 1.00e+00 | 4.263 | 2 | 2 | 25 |
GO:0005844 | polysome | 4.82e-03 | 1.00e+00 | 4.263 | 2 | 2 | 25 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 5.21e-03 | 1.00e+00 | 4.207 | 2 | 2 | 26 |
GO:0005978 | glycogen biosynthetic process | 5.21e-03 | 1.00e+00 | 4.207 | 2 | 2 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 5.21e-03 | 1.00e+00 | 4.207 | 2 | 2 | 26 |
GO:0045184 | establishment of protein localization | 5.61e-03 | 1.00e+00 | 4.152 | 2 | 2 | 27 |
GO:0043065 | positive regulation of apoptotic process | 5.67e-03 | 1.00e+00 | 2.131 | 5 | 6 | 274 |
GO:0007017 | microtubule-based process | 6.03e-03 | 1.00e+00 | 4.100 | 2 | 2 | 28 |
GO:0031252 | cell leading edge | 6.46e-03 | 1.00e+00 | 4.049 | 2 | 3 | 29 |
GO:0000922 | spindle pole | 6.47e-03 | 1.00e+00 | 2.984 | 3 | 5 | 91 |
GO:0010977 | negative regulation of neuron projection development | 6.90e-03 | 1.00e+00 | 4.000 | 2 | 2 | 30 |
GO:0007346 | regulation of mitotic cell cycle | 6.90e-03 | 1.00e+00 | 4.000 | 2 | 3 | 30 |
GO:0001649 | osteoblast differentiation | 7.29e-03 | 1.00e+00 | 2.922 | 3 | 3 | 95 |
GO:0007093 | mitotic cell cycle checkpoint | 7.36e-03 | 1.00e+00 | 3.953 | 2 | 2 | 31 |
GO:0032480 | negative regulation of type I interferon production | 7.83e-03 | 1.00e+00 | 3.907 | 2 | 2 | 32 |
GO:0071456 | cellular response to hypoxia | 7.94e-03 | 1.00e+00 | 2.877 | 3 | 3 | 98 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 8.27e-03 | 1.00e+00 | 2.330 | 4 | 5 | 191 |
GO:0046185 | aldehyde catabolic process | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0036035 | osteoclast development | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:1990077 | primosome complex | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 2 | 2 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0030892 | mitotic cohesin complex | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0051081 | nuclear envelope disassembly | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0007092 | activation of mitotic anaphase-promoting complex activity | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0010632 | regulation of epithelial cell migration | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0048257 | 3'-flap endonuclease activity | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0031134 | sister chromatid biorientation | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0060265 | positive regulation of respiratory burst involved in inflammatory response | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 8.32e-03 | 1.00e+00 | 6.907 | 1 | 1 | 2 |
GO:0007611 | learning or memory | 8.81e-03 | 1.00e+00 | 3.820 | 2 | 2 | 34 |
GO:0006915 | apoptotic process | 9.48e-03 | 1.00e+00 | 1.557 | 7 | 9 | 571 |
GO:0034332 | adherens junction organization | 9.84e-03 | 1.00e+00 | 3.737 | 2 | 4 | 36 |
GO:0003924 | GTPase activity | 1.02e-02 | 1.00e+00 | 2.242 | 4 | 6 | 203 |
GO:0016301 | kinase activity | 1.04e-02 | 1.00e+00 | 3.698 | 2 | 2 | 37 |
GO:0019901 | protein kinase binding | 1.07e-02 | 1.00e+00 | 1.907 | 5 | 9 | 320 |
GO:0030218 | erythrocyte differentiation | 1.09e-02 | 1.00e+00 | 3.659 | 2 | 2 | 38 |
GO:0050681 | androgen receptor binding | 1.09e-02 | 1.00e+00 | 3.659 | 2 | 2 | 38 |
GO:0097191 | extrinsic apoptotic signaling pathway | 1.09e-02 | 1.00e+00 | 3.659 | 2 | 3 | 38 |
GO:0005815 | microtubule organizing center | 1.09e-02 | 1.00e+00 | 2.711 | 3 | 4 | 110 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.11e-02 | 1.00e+00 | 1.512 | 7 | 9 | 589 |
GO:0015630 | microtubule cytoskeleton | 1.14e-02 | 1.00e+00 | 2.685 | 3 | 4 | 112 |
GO:0021766 | hippocampus development | 1.15e-02 | 1.00e+00 | 3.622 | 2 | 3 | 39 |
GO:0051106 | positive regulation of DNA ligation | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0010997 | anaphase-promoting complex binding | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0090045 | positive regulation of deacetylase activity | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0035033 | histone deacetylase regulator activity | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:2000017 | positive regulation of determination of dorsal identity | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0072757 | cellular response to camptothecin | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0045132 | meiotic chromosome segregation | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0045505 | dynein intermediate chain binding | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0050779 | RNA destabilization | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0033146 | regulation of intracellular estrogen receptor signaling pathway | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0004705 | JUN kinase activity | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0000942 | condensed nuclear chromosome outer kinetochore | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0043142 | single-stranded DNA-dependent ATPase activity | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0021540 | corpus callosum morphogenesis | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.24e-02 | 1.00e+00 | 6.322 | 1 | 1 | 3 |
GO:0097190 | apoptotic signaling pathway | 1.25e-02 | 1.00e+00 | 2.634 | 3 | 3 | 116 |
GO:0030521 | androgen receptor signaling pathway | 1.26e-02 | 1.00e+00 | 3.549 | 2 | 3 | 41 |
GO:0006006 | glucose metabolic process | 1.34e-02 | 1.00e+00 | 2.597 | 3 | 4 | 119 |
GO:0006184 | GTP catabolic process | 1.34e-02 | 1.00e+00 | 2.126 | 4 | 6 | 220 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 1.38e-02 | 1.00e+00 | 3.481 | 2 | 2 | 43 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.47e-02 | 1.00e+00 | 2.549 | 3 | 3 | 123 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.53e-02 | 1.00e+00 | 2.526 | 3 | 3 | 125 |
GO:0007219 | Notch signaling pathway | 1.53e-02 | 1.00e+00 | 2.526 | 3 | 4 | 125 |
GO:0008344 | adult locomotory behavior | 1.64e-02 | 1.00e+00 | 3.352 | 2 | 2 | 47 |
GO:0030686 | 90S preribosome | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0071922 | regulation of cohesin localization to chromatin | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 2 | 4 |
GO:0034191 | apolipoprotein A-I receptor binding | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0007000 | nucleolus organization | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 2 | 4 |
GO:0040038 | polar body extrusion after meiotic divisions | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0009301 | snRNA transcription | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0032463 | negative regulation of protein homooligomerization | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0051902 | negative regulation of mitochondrial depolarization | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0060020 | Bergmann glial cell differentiation | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0031062 | positive regulation of histone methylation | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0060684 | epithelial-mesenchymal cell signaling | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0070851 | growth factor receptor binding | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0051835 | positive regulation of synapse structural plasticity | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0043550 | regulation of lipid kinase activity | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0006222 | UMP biosynthetic process | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0090231 | regulation of spindle checkpoint | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0003896 | DNA primase activity | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 2 | 4 |
GO:0007258 | JUN phosphorylation | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0072429 | response to intra-S DNA damage checkpoint signaling | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0048664 | neuron fate determination | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0033503 | HULC complex | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0030036 | actin cytoskeleton organization | 1.66e-02 | 1.00e+00 | 2.481 | 3 | 3 | 129 |
GO:0045682 | regulation of epidermis development | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0031063 | regulation of histone deacetylation | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0000055 | ribosomal large subunit export from nucleus | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0035189 | Rb-E2F complex | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0033625 | positive regulation of integrin activation | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0034349 | glial cell apoptotic process | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0009991 | response to extracellular stimulus | 1.66e-02 | 1.00e+00 | 5.907 | 1 | 1 | 4 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.70e-02 | 1.00e+00 | 2.470 | 3 | 4 | 130 |
GO:0035690 | cellular response to drug | 1.84e-02 | 1.00e+00 | 3.263 | 2 | 3 | 50 |
GO:0016042 | lipid catabolic process | 1.98e-02 | 1.00e+00 | 3.207 | 2 | 2 | 52 |
GO:2000641 | regulation of early endosome to late endosome transport | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0036336 | dendritic cell migration | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0000779 | condensed chromosome, centromeric region | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0051385 | response to mineralocorticoid | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0006269 | DNA replication, synthesis of RNA primer | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 2 | 5 |
GO:0006312 | mitotic recombination | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:1902188 | positive regulation of viral release from host cell | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0097300 | programmed necrotic cell death | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0071168 | protein localization to chromatin | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0031256 | leading edge membrane | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0001515 | opioid peptide activity | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0008420 | CTD phosphatase activity | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0031023 | microtubule organizing center organization | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0071803 | positive regulation of podosome assembly | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0000730 | DNA recombinase assembly | 2.07e-02 | 1.00e+00 | 5.585 | 1 | 1 | 5 |
GO:0030666 | endocytic vesicle membrane | 2.13e-02 | 1.00e+00 | 3.152 | 2 | 2 | 54 |
GO:0019900 | kinase binding | 2.13e-02 | 1.00e+00 | 3.152 | 2 | 3 | 54 |
GO:0043025 | neuronal cell body | 2.15e-02 | 1.00e+00 | 1.918 | 4 | 5 | 254 |
GO:0048471 | perinuclear region of cytoplasm | 2.16e-02 | 1.00e+00 | 1.461 | 6 | 9 | 523 |
GO:0008286 | insulin receptor signaling pathway | 2.22e-02 | 1.00e+00 | 2.322 | 3 | 4 | 144 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 2.39e-02 | 1.00e+00 | 2.282 | 3 | 3 | 148 |
GO:0010628 | positive regulation of gene expression | 2.43e-02 | 1.00e+00 | 2.273 | 3 | 4 | 149 |
GO:0006281 | DNA repair | 2.43e-02 | 1.00e+00 | 1.863 | 4 | 5 | 264 |
GO:0043353 | enucleate erythrocyte differentiation | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0050847 | progesterone receptor signaling pathway | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0007143 | female meiotic division | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0002309 | T cell proliferation involved in immune response | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0004704 | NF-kappaB-inducing kinase activity | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0010457 | centriole-centriole cohesion | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0045056 | transcytosis | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0060789 | hair follicle placode formation | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0008090 | retrograde axon cargo transport | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0048554 | positive regulation of metalloenzyme activity | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0048029 | monosaccharide binding | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0050792 | regulation of viral process | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0019215 | intermediate filament binding | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0001667 | ameboidal-type cell migration | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0043196 | varicosity | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0034452 | dynactin binding | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 1 | 6 |
GO:0006924 | activation-induced cell death of T cells | 2.47e-02 | 1.00e+00 | 5.322 | 1 | 2 | 6 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.71e-02 | 1.00e+00 | 1.814 | 4 | 5 | 273 |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 2.84e-02 | 1.00e+00 | 2.930 | 2 | 2 | 63 |
GO:0006417 | regulation of translation | 2.84e-02 | 1.00e+00 | 2.930 | 2 | 4 | 63 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 2.87e-02 | 1.00e+00 | 2.179 | 3 | 3 | 159 |
GO:0010447 | response to acidic pH | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0006893 | Golgi to plasma membrane transport | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0060136 | embryonic process involved in female pregnancy | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0043497 | regulation of protein heterodimerization activity | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0050658 | RNA transport | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0048027 | mRNA 5'-UTR binding | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0061512 | protein localization to cilium | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0003334 | keratinocyte development | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0034101 | erythrocyte homeostasis | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0010907 | positive regulation of glucose metabolic process | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0030157 | pancreatic juice secretion | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0017145 | stem cell division | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0000930 | gamma-tubulin complex | 2.88e-02 | 1.00e+00 | 5.100 | 1 | 1 | 7 |
GO:0032869 | cellular response to insulin stimulus | 2.92e-02 | 1.00e+00 | 2.907 | 2 | 2 | 64 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 2.92e-02 | 1.00e+00 | 2.907 | 2 | 2 | 64 |
GO:0008022 | protein C-terminus binding | 2.96e-02 | 1.00e+00 | 2.161 | 3 | 4 | 161 |
GO:0005882 | intermediate filament | 3.09e-02 | 1.00e+00 | 2.863 | 2 | 3 | 66 |
GO:0071260 | cellular response to mechanical stimulus | 3.09e-02 | 1.00e+00 | 2.863 | 2 | 3 | 66 |
GO:0006310 | DNA recombination | 3.18e-02 | 1.00e+00 | 2.841 | 2 | 2 | 67 |
GO:0007264 | small GTPase mediated signal transduction | 3.28e-02 | 1.00e+00 | 1.727 | 4 | 7 | 290 |
GO:0051156 | glucose 6-phosphate metabolic process | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0090005 | negative regulation of establishment of protein localization to plasma membrane | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0000800 | lateral element | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0031512 | motile primary cilium | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0047498 | calcium-dependent phospholipase A2 activity | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0039702 | viral budding via host ESCRT complex | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0006183 | GTP biosynthetic process | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0043114 | regulation of vascular permeability | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0007289 | spermatid nucleus differentiation | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0005522 | profilin binding | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0070182 | DNA polymerase binding | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0005869 | dynactin complex | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0045124 | regulation of bone resorption | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0051489 | regulation of filopodium assembly | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0033523 | histone H2B ubiquitination | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0007172 | signal complex assembly | 3.29e-02 | 1.00e+00 | 4.907 | 1 | 1 | 8 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 3.45e-02 | 1.00e+00 | 2.074 | 3 | 3 | 171 |
GO:0016591 | DNA-directed RNA polymerase II, holoenzyme | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0097284 | hepatocyte apoptotic process | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0038061 | NIK/NF-kappaB signaling | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0000075 | cell cycle checkpoint | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0071732 | cellular response to nitric oxide | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0006241 | CTP biosynthetic process | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0021895 | cerebral cortex neuron differentiation | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0014075 | response to amine | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0006228 | UTP biosynthetic process | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0090136 | epithelial cell-cell adhesion | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 2 | 9 |
GO:0047497 | mitochondrion transport along microtubule | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0032319 | regulation of Rho GTPase activity | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0007599 | hemostasis | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0005031 | tumor necrosis factor-activated receptor activity | 3.69e-02 | 1.00e+00 | 4.737 | 1 | 1 | 9 |
GO:0003729 | mRNA binding | 3.72e-02 | 1.00e+00 | 2.717 | 2 | 3 | 73 |
GO:0000785 | chromatin | 3.72e-02 | 1.00e+00 | 2.717 | 2 | 2 | 73 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3.72e-02 | 1.00e+00 | 2.717 | 2 | 2 | 73 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.76e-02 | 1.00e+00 | 2.024 | 3 | 5 | 177 |
GO:0004672 | protein kinase activity | 3.82e-02 | 1.00e+00 | 2.016 | 3 | 4 | 178 |
GO:0007265 | Ras protein signal transduction | 3.91e-02 | 1.00e+00 | 2.678 | 2 | 3 | 75 |
GO:0031625 | ubiquitin protein ligase binding | 3.92e-02 | 1.00e+00 | 2.000 | 3 | 4 | 180 |
GO:0045618 | positive regulation of keratinocyte differentiation | 4.09e-02 | 1.00e+00 | 4.585 | 1 | 1 | 10 |
GO:0032040 | small-subunit processome | 4.09e-02 | 1.00e+00 | 4.585 | 1 | 1 | 10 |
GO:0070307 | lens fiber cell development | 4.09e-02 | 1.00e+00 | 4.585 | 1 | 1 | 10 |
GO:0006268 | DNA unwinding involved in DNA replication | 4.09e-02 | 1.00e+00 | 4.585 | 1 | 1 | 10 |
GO:0005798 | Golgi-associated vesicle | 4.09e-02 | 1.00e+00 | 4.585 | 1 | 1 | 10 |
GO:0017049 | GTP-Rho binding | 4.09e-02 | 1.00e+00 | 4.585 | 1 | 1 | 10 |
GO:0022407 | regulation of cell-cell adhesion | 4.09e-02 | 1.00e+00 | 4.585 | 1 | 1 | 10 |
GO:0001675 | acrosome assembly | 4.09e-02 | 1.00e+00 | 4.585 | 1 | 1 | 10 |
GO:0060047 | heart contraction | 4.09e-02 | 1.00e+00 | 4.585 | 1 | 1 | 10 |
GO:0044325 | ion channel binding | 4.10e-02 | 1.00e+00 | 2.640 | 2 | 3 | 77 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.10e-02 | 1.00e+00 | 2.640 | 2 | 4 | 77 |
GO:0044281 | small molecule metabolic process | 4.11e-02 | 1.00e+00 | 0.890 | 10 | 16 | 1295 |
GO:0007229 | integrin-mediated signaling pathway | 4.19e-02 | 1.00e+00 | 2.622 | 2 | 2 | 78 |
GO:0045087 | innate immune response | 4.29e-02 | 1.00e+00 | 1.225 | 6 | 11 | 616 |
GO:0010629 | negative regulation of gene expression | 4.39e-02 | 1.00e+00 | 2.585 | 2 | 2 | 80 |
GO:0045502 | dynein binding | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0045176 | apical protein localization | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0051895 | negative regulation of focal adhesion assembly | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0042551 | neuron maturation | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0045651 | positive regulation of macrophage differentiation | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:2000573 | positive regulation of DNA biosynthetic process | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 2 | 11 |
GO:0051272 | positive regulation of cellular component movement | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0045109 | intermediate filament organization | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0060065 | uterus development | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0010390 | histone monoubiquitination | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0035518 | histone H2A monoubiquitination | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 2 | 11 |
GO:0014002 | astrocyte development | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0021819 | layer formation in cerebral cortex | 4.49e-02 | 1.00e+00 | 4.448 | 1 | 1 | 11 |
GO:0005525 | GTP binding | 4.79e-02 | 1.00e+00 | 1.549 | 4 | 6 | 328 |
GO:0061136 | regulation of proteasomal protein catabolic process | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 1 | 12 |
GO:0007051 | spindle organization | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 1 | 12 |
GO:0051146 | striated muscle cell differentiation | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 2 | 12 |
GO:0043149 | stress fiber assembly | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 2 | 12 |
GO:0030140 | trans-Golgi network transport vesicle | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 1 | 12 |
GO:0047496 | vesicle transport along microtubule | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 1 | 12 |
GO:1903543 | positive regulation of exosomal secretion | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 1 | 12 |
GO:0036150 | phosphatidylserine acyl-chain remodeling | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 1 | 12 |
GO:1901214 | regulation of neuron death | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 1 | 12 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.13e-02 | 1.00e+00 | 1.051 | 7 | 11 | 811 |
GO:0050852 | T cell receptor signaling pathway | 5.21e-02 | 1.00e+00 | 2.448 | 2 | 2 | 88 |
GO:0043488 | regulation of mRNA stability | 5.28e-02 | 1.00e+00 | 4.207 | 1 | 1 | 13 |
GO:0031929 | TOR signaling | 5.28e-02 | 1.00e+00 | 4.207 | 1 | 1 | 13 |
GO:0036149 | phosphatidylinositol acyl-chain remodeling | 5.28e-02 | 1.00e+00 | 4.207 | 1 | 1 | 13 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 5.28e-02 | 1.00e+00 | 4.207 | 1 | 1 | 13 |
GO:0000187 | activation of MAPK activity | 5.42e-02 | 1.00e+00 | 2.415 | 2 | 3 | 90 |
GO:0003690 | double-stranded DNA binding | 5.53e-02 | 1.00e+00 | 2.399 | 2 | 2 | 91 |
GO:0016605 | PML body | 5.63e-02 | 1.00e+00 | 2.383 | 2 | 2 | 92 |
GO:0035371 | microtubule plus-end | 5.68e-02 | 1.00e+00 | 4.100 | 1 | 1 | 14 |
GO:0031333 | negative regulation of protein complex assembly | 5.68e-02 | 1.00e+00 | 4.100 | 1 | 1 | 14 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 5.68e-02 | 1.00e+00 | 4.100 | 1 | 1 | 14 |
GO:0050662 | coenzyme binding | 5.68e-02 | 1.00e+00 | 4.100 | 1 | 1 | 14 |
GO:0031996 | thioesterase binding | 5.68e-02 | 1.00e+00 | 4.100 | 1 | 1 | 14 |
GO:0006165 | nucleoside diphosphate phosphorylation | 5.68e-02 | 1.00e+00 | 4.100 | 1 | 1 | 14 |
GO:0031334 | positive regulation of protein complex assembly | 5.68e-02 | 1.00e+00 | 4.100 | 1 | 1 | 14 |
GO:0005200 | structural constituent of cytoskeleton | 5.74e-02 | 1.00e+00 | 2.368 | 2 | 6 | 93 |
GO:0051443 | positive regulation of ubiquitin-protein transferase activity | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 15 |
GO:0048477 | oogenesis | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 15 |
GO:0030131 | clathrin adaptor complex | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 15 |
GO:0030225 | macrophage differentiation | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 15 |
GO:0036148 | phosphatidylglycerol acyl-chain remodeling | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 15 |
GO:0016514 | SWI/SNF complex | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 15 |
GO:0045445 | myoblast differentiation | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 15 |
GO:0004550 | nucleoside diphosphate kinase activity | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 15 |
GO:0048821 | erythrocyte development | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 2 | 15 |
GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 15 |
GO:0031369 | translation initiation factor binding | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 2 | 15 |
GO:0005762 | mitochondrial large ribosomal subunit | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 15 |
GO:0048854 | brain morphogenesis | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 15 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 15 |
GO:0007405 | neuroblast proliferation | 6.46e-02 | 1.00e+00 | 3.907 | 1 | 1 | 16 |
GO:0014911 | positive regulation of smooth muscle cell migration | 6.46e-02 | 1.00e+00 | 3.907 | 1 | 1 | 16 |
GO:0048037 | cofactor binding | 6.46e-02 | 1.00e+00 | 3.907 | 1 | 1 | 16 |
GO:0019226 | transmission of nerve impulse | 6.46e-02 | 1.00e+00 | 3.907 | 1 | 1 | 16 |
GO:0000132 | establishment of mitotic spindle orientation | 6.46e-02 | 1.00e+00 | 3.907 | 1 | 2 | 16 |
GO:2000811 | negative regulation of anoikis | 6.46e-02 | 1.00e+00 | 3.907 | 1 | 1 | 16 |
GO:0005212 | structural constituent of eye lens | 6.46e-02 | 1.00e+00 | 3.907 | 1 | 1 | 16 |
GO:0030675 | Rac GTPase activator activity | 6.46e-02 | 1.00e+00 | 3.907 | 1 | 1 | 16 |
GO:0002548 | monocyte chemotaxis | 6.85e-02 | 1.00e+00 | 3.820 | 1 | 1 | 17 |
GO:0043274 | phospholipase binding | 6.85e-02 | 1.00e+00 | 3.820 | 1 | 1 | 17 |
GO:0030742 | GTP-dependent protein binding | 6.85e-02 | 1.00e+00 | 3.820 | 1 | 1 | 17 |
GO:0007126 | meiotic nuclear division | 6.85e-02 | 1.00e+00 | 3.820 | 1 | 1 | 17 |
GO:0008360 | regulation of cell shape | 7.22e-02 | 1.00e+00 | 2.179 | 2 | 2 | 106 |
GO:0014069 | postsynaptic density | 7.22e-02 | 1.00e+00 | 2.179 | 2 | 3 | 106 |
GO:0070064 | proline-rich region binding | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 1 | 18 |
GO:0006612 | protein targeting to membrane | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 2 | 18 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 1 | 18 |
GO:0045773 | positive regulation of axon extension | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 1 | 18 |
GO:0004709 | MAP kinase kinase kinase activity | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 1 | 18 |
GO:0031954 | positive regulation of protein autophosphorylation | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 1 | 18 |
GO:0015949 | nucleobase-containing small molecule interconversion | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 1 | 18 |
GO:0043015 | gamma-tubulin binding | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 2 | 18 |
GO:0036152 | phosphatidylethanolamine acyl-chain remodeling | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 1 | 18 |
GO:0090316 | positive regulation of intracellular protein transport | 7.24e-02 | 1.00e+00 | 3.737 | 1 | 1 | 18 |
GO:0030496 | midbody | 7.58e-02 | 1.00e+00 | 2.139 | 2 | 4 | 109 |
GO:0006259 | DNA metabolic process | 7.63e-02 | 1.00e+00 | 3.659 | 1 | 1 | 19 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 7.63e-02 | 1.00e+00 | 3.659 | 1 | 1 | 19 |
GO:0031572 | G2 DNA damage checkpoint | 7.63e-02 | 1.00e+00 | 3.659 | 1 | 1 | 19 |
GO:0007088 | regulation of mitosis | 7.63e-02 | 1.00e+00 | 3.659 | 1 | 1 | 19 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 7.63e-02 | 1.00e+00 | 3.659 | 1 | 1 | 19 |
GO:0017134 | fibroblast growth factor binding | 7.63e-02 | 1.00e+00 | 3.659 | 1 | 2 | 19 |
GO:0045453 | bone resorption | 7.63e-02 | 1.00e+00 | 3.659 | 1 | 1 | 19 |
GO:0031667 | response to nutrient levels | 7.63e-02 | 1.00e+00 | 3.659 | 1 | 1 | 19 |
GO:0000070 | mitotic sister chromatid segregation | 7.63e-02 | 1.00e+00 | 3.659 | 1 | 1 | 19 |
GO:0030866 | cortical actin cytoskeleton organization | 7.63e-02 | 1.00e+00 | 3.659 | 1 | 1 | 19 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 8.02e-02 | 1.00e+00 | 3.585 | 1 | 1 | 20 |
GO:0032148 | activation of protein kinase B activity | 8.02e-02 | 1.00e+00 | 3.585 | 1 | 1 | 20 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 8.02e-02 | 1.00e+00 | 3.585 | 1 | 2 | 20 |
GO:0001578 | microtubule bundle formation | 8.02e-02 | 1.00e+00 | 3.585 | 1 | 1 | 20 |
GO:0043473 | pigmentation | 8.02e-02 | 1.00e+00 | 3.585 | 1 | 2 | 20 |
GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 8.02e-02 | 1.00e+00 | 3.585 | 1 | 1 | 20 |
GO:0005819 | spindle | 8.18e-02 | 1.00e+00 | 2.074 | 2 | 4 | 114 |
GO:0007369 | gastrulation | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 1 | 21 |
GO:0045862 | positive regulation of proteolysis | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 1 | 21 |
GO:0000793 | condensed chromosome | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 2 | 21 |
GO:0005689 | U12-type spliceosomal complex | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 2 | 21 |
GO:0046847 | filopodium assembly | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 1 | 21 |
GO:0009306 | protein secretion | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 2 | 21 |
GO:0031648 | protein destabilization | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 1 | 21 |
GO:0051881 | regulation of mitochondrial membrane potential | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 1 | 21 |
GO:0000281 | mitotic cytokinesis | 8.40e-02 | 1.00e+00 | 3.515 | 1 | 1 | 21 |
GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 8.78e-02 | 1.00e+00 | 3.448 | 1 | 1 | 22 |
GO:0046686 | response to cadmium ion | 8.78e-02 | 1.00e+00 | 3.448 | 1 | 1 | 22 |
GO:0033574 | response to testosterone | 8.78e-02 | 1.00e+00 | 3.448 | 1 | 1 | 22 |
GO:0001106 | RNA polymerase II transcription corepressor activity | 8.78e-02 | 1.00e+00 | 3.448 | 1 | 1 | 22 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 8.78e-02 | 1.00e+00 | 3.448 | 1 | 1 | 22 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 8.78e-02 | 1.00e+00 | 3.448 | 1 | 1 | 22 |
GO:0032201 | telomere maintenance via semi-conservative replication | 8.78e-02 | 1.00e+00 | 3.448 | 1 | 2 | 22 |
GO:0036151 | phosphatidylcholine acyl-chain remodeling | 8.78e-02 | 1.00e+00 | 3.448 | 1 | 1 | 22 |
GO:0006270 | DNA replication initiation | 8.78e-02 | 1.00e+00 | 3.448 | 1 | 2 | 22 |
GO:0007052 | mitotic spindle organization | 8.78e-02 | 1.00e+00 | 3.448 | 1 | 1 | 22 |
GO:0000139 | Golgi membrane | 9.03e-02 | 1.00e+00 | 1.235 | 4 | 7 | 408 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 9.16e-02 | 1.00e+00 | 3.383 | 1 | 1 | 23 |
GO:0051491 | positive regulation of filopodium assembly | 9.16e-02 | 1.00e+00 | 3.383 | 1 | 2 | 23 |
GO:0071944 | cell periphery | 9.16e-02 | 1.00e+00 | 3.383 | 1 | 1 | 23 |
GO:0045787 | positive regulation of cell cycle | 9.16e-02 | 1.00e+00 | 3.383 | 1 | 2 | 23 |
GO:0002040 | sprouting angiogenesis | 9.16e-02 | 1.00e+00 | 3.383 | 1 | 1 | 23 |
GO:0045879 | negative regulation of smoothened signaling pathway | 9.16e-02 | 1.00e+00 | 3.383 | 1 | 1 | 23 |
GO:0051017 | actin filament bundle assembly | 9.16e-02 | 1.00e+00 | 3.383 | 1 | 1 | 23 |
GO:0001892 | embryonic placenta development | 9.16e-02 | 1.00e+00 | 3.383 | 1 | 1 | 23 |
GO:0007131 | reciprocal meiotic recombination | 9.54e-02 | 1.00e+00 | 3.322 | 1 | 1 | 24 |
GO:0046329 | negative regulation of JNK cascade | 9.54e-02 | 1.00e+00 | 3.322 | 1 | 1 | 24 |
GO:0007163 | establishment or maintenance of cell polarity | 9.54e-02 | 1.00e+00 | 3.322 | 1 | 2 | 24 |
GO:0005100 | Rho GTPase activator activity | 9.54e-02 | 1.00e+00 | 3.322 | 1 | 1 | 24 |
GO:0000794 | condensed nuclear chromosome | 9.54e-02 | 1.00e+00 | 3.322 | 1 | 1 | 24 |
GO:0006206 | pyrimidine nucleobase metabolic process | 9.54e-02 | 1.00e+00 | 3.322 | 1 | 1 | 24 |
GO:0051602 | response to electrical stimulus | 9.54e-02 | 1.00e+00 | 3.322 | 1 | 1 | 24 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 9.83e-02 | 1.00e+00 | 1.918 | 2 | 3 | 127 |
GO:0006611 | protein export from nucleus | 9.92e-02 | 1.00e+00 | 3.263 | 1 | 1 | 25 |
GO:0006654 | phosphatidic acid biosynthetic process | 9.92e-02 | 1.00e+00 | 3.263 | 1 | 1 | 25 |
GO:0031519 | PcG protein complex | 9.92e-02 | 1.00e+00 | 3.263 | 1 | 1 | 25 |
GO:0071479 | cellular response to ionizing radiation | 9.92e-02 | 1.00e+00 | 3.263 | 1 | 2 | 25 |
GO:0050715 | positive regulation of cytokine secretion | 9.92e-02 | 1.00e+00 | 3.263 | 1 | 1 | 25 |
GO:0046326 | positive regulation of glucose import | 9.92e-02 | 1.00e+00 | 3.263 | 1 | 1 | 25 |
GO:0048705 | skeletal system morphogenesis | 9.92e-02 | 1.00e+00 | 3.263 | 1 | 1 | 25 |
GO:0045931 | positive regulation of mitotic cell cycle | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 2 | 26 |
GO:0000045 | autophagic vacuole assembly | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 26 |
GO:0045859 | regulation of protein kinase activity | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 26 |
GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 26 |
GO:0000722 | telomere maintenance via recombination | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 2 | 26 |
GO:0009615 | response to virus | 1.05e-01 | 1.00e+00 | 1.863 | 2 | 4 | 132 |
GO:0005975 | carbohydrate metabolic process | 1.06e-01 | 1.00e+00 | 1.394 | 3 | 3 | 274 |
GO:0051149 | positive regulation of muscle cell differentiation | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 2 | 27 |
GO:0032720 | negative regulation of tumor necrosis factor production | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 1 | 27 |
GO:0005083 | small GTPase regulator activity | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 1 | 27 |
GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 1 | 27 |
GO:0031424 | keratinization | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 1 | 27 |
GO:0001103 | RNA polymerase II repressing transcription factor binding | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 1 | 27 |
GO:0030331 | estrogen receptor binding | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 1 | 27 |
GO:0048565 | digestive tract development | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 1 | 27 |
GO:0051258 | protein polymerization | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 1 | 27 |
GO:0031069 | hair follicle morphogenesis | 1.07e-01 | 1.00e+00 | 3.152 | 1 | 1 | 27 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 1.10e-01 | 1.00e+00 | 3.100 | 1 | 1 | 28 |
GO:0032467 | positive regulation of cytokinesis | 1.10e-01 | 1.00e+00 | 3.100 | 1 | 1 | 28 |
GO:0005875 | microtubule associated complex | 1.10e-01 | 1.00e+00 | 3.100 | 1 | 1 | 28 |
GO:0042626 | ATPase activity, coupled to transmembrane movement of substances | 1.10e-01 | 1.00e+00 | 3.100 | 1 | 1 | 28 |
GO:0019005 | SCF ubiquitin ligase complex | 1.14e-01 | 1.00e+00 | 3.049 | 1 | 1 | 29 |
GO:0003730 | mRNA 3'-UTR binding | 1.14e-01 | 1.00e+00 | 3.049 | 1 | 1 | 29 |
GO:0034605 | cellular response to heat | 1.14e-01 | 1.00e+00 | 3.049 | 1 | 1 | 29 |
GO:0072686 | mitotic spindle | 1.14e-01 | 1.00e+00 | 3.049 | 1 | 1 | 29 |
GO:0051262 | protein tetramerization | 1.18e-01 | 1.00e+00 | 3.000 | 1 | 1 | 30 |
GO:0042254 | ribosome biogenesis | 1.18e-01 | 1.00e+00 | 3.000 | 1 | 1 | 30 |
GO:0046875 | ephrin receptor binding | 1.18e-01 | 1.00e+00 | 3.000 | 1 | 2 | 30 |
GO:0042169 | SH2 domain binding | 1.18e-01 | 1.00e+00 | 3.000 | 1 | 1 | 30 |
GO:0031647 | regulation of protein stability | 1.18e-01 | 1.00e+00 | 3.000 | 1 | 1 | 30 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.18e-01 | 1.00e+00 | 3.000 | 1 | 1 | 30 |
GO:0040018 | positive regulation of multicellular organism growth | 1.18e-01 | 1.00e+00 | 3.000 | 1 | 1 | 30 |
GO:0010494 | cytoplasmic stress granule | 1.18e-01 | 1.00e+00 | 3.000 | 1 | 2 | 30 |
GO:0070555 | response to interleukin-1 | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 1 | 31 |
GO:0045171 | intercellular bridge | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 2 | 31 |
GO:0006271 | DNA strand elongation involved in DNA replication | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 2 | 31 |
GO:0046677 | response to antibiotic | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 1 | 31 |
GO:0007094 | mitotic spindle assembly checkpoint | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 1 | 31 |
GO:0033572 | transferrin transport | 1.25e-01 | 1.00e+00 | 2.907 | 1 | 1 | 32 |
GO:0015992 | proton transport | 1.25e-01 | 1.00e+00 | 2.907 | 1 | 1 | 32 |
GO:0032091 | negative regulation of protein binding | 1.29e-01 | 1.00e+00 | 2.863 | 1 | 1 | 33 |
GO:0008017 | microtubule binding | 1.29e-01 | 1.00e+00 | 1.678 | 2 | 2 | 150 |
GO:0005158 | insulin receptor binding | 1.29e-01 | 1.00e+00 | 2.863 | 1 | 2 | 33 |
GO:0033077 | T cell differentiation in thymus | 1.29e-01 | 1.00e+00 | 2.863 | 1 | 1 | 33 |
GO:0048812 | neuron projection morphogenesis | 1.29e-01 | 1.00e+00 | 2.863 | 1 | 1 | 33 |
GO:0051260 | protein homooligomerization | 1.29e-01 | 1.00e+00 | 1.678 | 2 | 2 | 150 |
GO:0043234 | protein complex | 1.30e-01 | 1.00e+00 | 1.263 | 3 | 9 | 300 |
GO:0001890 | placenta development | 1.32e-01 | 1.00e+00 | 2.820 | 1 | 1 | 34 |
GO:0097110 | scaffold protein binding | 1.32e-01 | 1.00e+00 | 2.820 | 1 | 1 | 34 |
GO:0042692 | muscle cell differentiation | 1.32e-01 | 1.00e+00 | 2.820 | 1 | 2 | 34 |
GO:0051701 | interaction with host | 1.32e-01 | 1.00e+00 | 2.820 | 1 | 1 | 34 |
GO:0005876 | spindle microtubule | 1.32e-01 | 1.00e+00 | 2.820 | 1 | 1 | 34 |
GO:0005794 | Golgi apparatus | 1.34e-01 | 1.00e+00 | 0.885 | 5 | 8 | 650 |
GO:0071333 | cellular response to glucose stimulus | 1.36e-01 | 1.00e+00 | 2.778 | 1 | 2 | 35 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 1.36e-01 | 1.00e+00 | 2.778 | 1 | 1 | 35 |
GO:0010008 | endosome membrane | 1.39e-01 | 1.00e+00 | 1.612 | 2 | 2 | 157 |
GO:0051402 | neuron apoptotic process | 1.40e-01 | 1.00e+00 | 2.737 | 1 | 1 | 36 |
GO:0032855 | positive regulation of Rac GTPase activity | 1.40e-01 | 1.00e+00 | 2.737 | 1 | 1 | 36 |
GO:0000228 | nuclear chromosome | 1.40e-01 | 1.00e+00 | 2.737 | 1 | 2 | 36 |
GO:0030838 | positive regulation of actin filament polymerization | 1.40e-01 | 1.00e+00 | 2.737 | 1 | 1 | 36 |
GO:0030178 | negative regulation of Wnt signaling pathway | 1.40e-01 | 1.00e+00 | 2.737 | 1 | 1 | 36 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 1.40e-01 | 1.00e+00 | 2.737 | 1 | 1 | 36 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 1.43e-01 | 1.00e+00 | 2.698 | 1 | 1 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.43e-01 | 1.00e+00 | 2.698 | 1 | 2 | 37 |
GO:0007077 | mitotic nuclear envelope disassembly | 1.43e-01 | 1.00e+00 | 2.698 | 1 | 1 | 37 |
GO:0018107 | peptidyl-threonine phosphorylation | 1.43e-01 | 1.00e+00 | 2.698 | 1 | 1 | 37 |
GO:0032880 | regulation of protein localization | 1.43e-01 | 1.00e+00 | 2.698 | 1 | 1 | 37 |
GO:0005739 | mitochondrion | 1.44e-01 | 1.00e+00 | 0.684 | 7 | 10 | 1046 |
GO:0045121 | membrane raft | 1.45e-01 | 1.00e+00 | 1.576 | 2 | 3 | 161 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.45e-01 | 1.00e+00 | 0.979 | 4 | 8 | 487 |
GO:0030049 | muscle filament sliding | 1.47e-01 | 1.00e+00 | 2.659 | 1 | 2 | 38 |
GO:0045740 | positive regulation of DNA replication | 1.47e-01 | 1.00e+00 | 2.659 | 1 | 1 | 38 |
GO:0090382 | phagosome maturation | 1.47e-01 | 1.00e+00 | 2.659 | 1 | 1 | 38 |
GO:0042802 | identical protein binding | 1.48e-01 | 1.00e+00 | 0.967 | 4 | 4 | 491 |
GO:0051781 | positive regulation of cell division | 1.50e-01 | 1.00e+00 | 2.622 | 1 | 1 | 39 |
GO:0006096 | glycolytic process | 1.50e-01 | 1.00e+00 | 2.622 | 1 | 1 | 39 |
GO:0032092 | positive regulation of protein binding | 1.50e-01 | 1.00e+00 | 2.622 | 1 | 1 | 39 |
GO:0000737 | DNA catabolic process, endonucleolytic | 1.50e-01 | 1.00e+00 | 2.622 | 1 | 1 | 39 |
GO:0007595 | lactation | 1.50e-01 | 1.00e+00 | 2.622 | 1 | 1 | 39 |
GO:0007015 | actin filament organization | 1.54e-01 | 1.00e+00 | 2.585 | 1 | 1 | 40 |
GO:0034220 | ion transmembrane transport | 1.54e-01 | 1.00e+00 | 1.523 | 2 | 2 | 167 |
GO:0042542 | response to hydrogen peroxide | 1.54e-01 | 1.00e+00 | 2.585 | 1 | 1 | 40 |
GO:0005881 | cytoplasmic microtubule | 1.58e-01 | 1.00e+00 | 2.549 | 1 | 1 | 41 |
GO:0070301 | cellular response to hydrogen peroxide | 1.58e-01 | 1.00e+00 | 2.549 | 1 | 1 | 41 |
GO:0045785 | positive regulation of cell adhesion | 1.58e-01 | 1.00e+00 | 2.549 | 1 | 1 | 41 |
GO:0050885 | neuromuscular process controlling balance | 1.58e-01 | 1.00e+00 | 2.549 | 1 | 1 | 41 |
GO:0021987 | cerebral cortex development | 1.61e-01 | 1.00e+00 | 2.515 | 1 | 1 | 42 |
GO:0071363 | cellular response to growth factor stimulus | 1.61e-01 | 1.00e+00 | 2.515 | 1 | 1 | 42 |
GO:0043231 | intracellular membrane-bounded organelle | 1.61e-01 | 1.00e+00 | 1.117 | 3 | 3 | 332 |
GO:0005902 | microvillus | 1.61e-01 | 1.00e+00 | 2.515 | 1 | 1 | 42 |
GO:0035914 | skeletal muscle cell differentiation | 1.61e-01 | 1.00e+00 | 2.515 | 1 | 1 | 42 |
GO:0004715 | non-membrane spanning protein tyrosine kinase activity | 1.61e-01 | 1.00e+00 | 2.515 | 1 | 1 | 42 |
GO:0003682 | chromatin binding | 1.63e-01 | 1.00e+00 | 1.108 | 3 | 4 | 334 |
GO:0031965 | nuclear membrane | 1.67e-01 | 1.00e+00 | 1.448 | 2 | 2 | 176 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.68e-01 | 1.00e+00 | 2.448 | 1 | 1 | 44 |
GO:0007286 | spermatid development | 1.68e-01 | 1.00e+00 | 2.448 | 1 | 1 | 44 |
GO:0005871 | kinesin complex | 1.68e-01 | 1.00e+00 | 2.448 | 1 | 1 | 44 |
GO:0005080 | protein kinase C binding | 1.68e-01 | 1.00e+00 | 2.448 | 1 | 1 | 44 |
GO:0034613 | cellular protein localization | 1.68e-01 | 1.00e+00 | 2.448 | 1 | 2 | 44 |
GO:0006094 | gluconeogenesis | 1.71e-01 | 1.00e+00 | 2.415 | 1 | 1 | 45 |
GO:0009411 | response to UV | 1.71e-01 | 1.00e+00 | 2.415 | 1 | 2 | 45 |
GO:0051591 | response to cAMP | 1.71e-01 | 1.00e+00 | 2.415 | 1 | 1 | 45 |
GO:0019904 | protein domain specific binding | 1.74e-01 | 1.00e+00 | 1.407 | 2 | 3 | 181 |
GO:0044297 | cell body | 1.75e-01 | 1.00e+00 | 2.383 | 1 | 1 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 1.75e-01 | 1.00e+00 | 2.383 | 1 | 2 | 46 |
GO:0045727 | positive regulation of translation | 1.75e-01 | 1.00e+00 | 2.383 | 1 | 1 | 46 |
GO:0021762 | substantia nigra development | 1.75e-01 | 1.00e+00 | 2.383 | 1 | 2 | 46 |
GO:0001047 | core promoter binding | 1.75e-01 | 1.00e+00 | 2.383 | 1 | 1 | 46 |
GO:0005884 | actin filament | 1.75e-01 | 1.00e+00 | 2.383 | 1 | 2 | 46 |
GO:0043406 | positive regulation of MAP kinase activity | 1.78e-01 | 1.00e+00 | 2.352 | 1 | 1 | 47 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 1.78e-01 | 1.00e+00 | 2.352 | 1 | 1 | 47 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.79e-01 | 1.00e+00 | 1.383 | 2 | 5 | 184 |
GO:0006950 | response to stress | 1.82e-01 | 1.00e+00 | 2.322 | 1 | 1 | 48 |
GO:0019003 | GDP binding | 1.82e-01 | 1.00e+00 | 2.322 | 1 | 1 | 48 |
GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 1.85e-01 | 1.00e+00 | 2.292 | 1 | 2 | 49 |
GO:0005070 | SH3/SH2 adaptor activity | 1.85e-01 | 1.00e+00 | 2.292 | 1 | 1 | 49 |
GO:0045111 | intermediate filament cytoskeleton | 1.85e-01 | 1.00e+00 | 2.292 | 1 | 1 | 49 |
GO:0015031 | protein transport | 1.86e-01 | 1.00e+00 | 1.012 | 3 | 4 | 357 |
GO:0001948 | glycoprotein binding | 1.89e-01 | 1.00e+00 | 2.263 | 1 | 2 | 50 |
GO:0007030 | Golgi organization | 1.89e-01 | 1.00e+00 | 2.263 | 1 | 3 | 50 |
GO:0000910 | cytokinesis | 1.92e-01 | 1.00e+00 | 2.235 | 1 | 2 | 51 |
GO:0003684 | damaged DNA binding | 1.92e-01 | 1.00e+00 | 2.235 | 1 | 2 | 51 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | 1.92e-01 | 1.00e+00 | 2.235 | 1 | 1 | 51 |
GO:0030900 | forebrain development | 1.92e-01 | 1.00e+00 | 2.235 | 1 | 1 | 51 |
GO:0006959 | humoral immune response | 1.95e-01 | 1.00e+00 | 2.207 | 1 | 1 | 52 |
GO:0008202 | steroid metabolic process | 1.95e-01 | 1.00e+00 | 2.207 | 1 | 1 | 52 |
GO:0000775 | chromosome, centromeric region | 1.95e-01 | 1.00e+00 | 2.207 | 1 | 1 | 52 |
GO:0004197 | cysteine-type endopeptidase activity | 1.95e-01 | 1.00e+00 | 2.207 | 1 | 2 | 52 |
GO:0030674 | protein binding, bridging | 1.95e-01 | 1.00e+00 | 2.207 | 1 | 1 | 52 |
GO:0006952 | defense response | 1.99e-01 | 1.00e+00 | 2.179 | 1 | 1 | 53 |
GO:0030175 | filopodium | 1.99e-01 | 1.00e+00 | 2.179 | 1 | 2 | 53 |
GO:0003725 | double-stranded RNA binding | 2.02e-01 | 1.00e+00 | 2.152 | 1 | 2 | 54 |
GO:0009612 | response to mechanical stimulus | 2.02e-01 | 1.00e+00 | 2.152 | 1 | 1 | 54 |
GO:0000186 | activation of MAPKK activity | 2.02e-01 | 1.00e+00 | 2.152 | 1 | 1 | 54 |
GO:0050680 | negative regulation of epithelial cell proliferation | 2.02e-01 | 1.00e+00 | 2.152 | 1 | 1 | 54 |
GO:0050679 | positive regulation of epithelial cell proliferation | 2.02e-01 | 1.00e+00 | 2.152 | 1 | 2 | 54 |
GO:0097193 | intrinsic apoptotic signaling pathway | 2.05e-01 | 1.00e+00 | 2.126 | 1 | 2 | 55 |
GO:0002039 | p53 binding | 2.05e-01 | 1.00e+00 | 2.126 | 1 | 1 | 55 |
GO:0008233 | peptidase activity | 2.05e-01 | 1.00e+00 | 2.126 | 1 | 1 | 55 |
GO:0000226 | microtubule cytoskeleton organization | 2.05e-01 | 1.00e+00 | 2.126 | 1 | 1 | 55 |
GO:0046330 | positive regulation of JNK cascade | 2.05e-01 | 1.00e+00 | 2.126 | 1 | 1 | 55 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 2.05e-01 | 1.00e+00 | 2.126 | 1 | 1 | 55 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 2.12e-01 | 1.00e+00 | 2.074 | 1 | 1 | 57 |
GO:0006879 | cellular iron ion homeostasis | 2.12e-01 | 1.00e+00 | 2.074 | 1 | 2 | 57 |
GO:0000724 | double-strand break repair via homologous recombination | 2.12e-01 | 1.00e+00 | 2.074 | 1 | 2 | 57 |
GO:0012505 | endomembrane system | 2.12e-01 | 1.00e+00 | 2.074 | 1 | 1 | 57 |
GO:0000723 | telomere maintenance | 2.19e-01 | 1.00e+00 | 2.024 | 1 | 2 | 59 |
GO:0005643 | nuclear pore | 2.19e-01 | 1.00e+00 | 2.024 | 1 | 1 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 2.19e-01 | 1.00e+00 | 2.024 | 1 | 1 | 59 |
GO:0050728 | negative regulation of inflammatory response | 2.22e-01 | 1.00e+00 | 2.000 | 1 | 2 | 60 |
GO:0010976 | positive regulation of neuron projection development | 2.22e-01 | 1.00e+00 | 2.000 | 1 | 2 | 60 |
GO:0008284 | positive regulation of cell proliferation | 2.24e-01 | 1.00e+00 | 0.877 | 3 | 7 | 392 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 2.25e-01 | 1.00e+00 | 1.976 | 1 | 1 | 61 |
GO:0035091 | phosphatidylinositol binding | 2.25e-01 | 1.00e+00 | 1.976 | 1 | 1 | 61 |
GO:0006302 | double-strand break repair | 2.28e-01 | 1.00e+00 | 1.953 | 1 | 2 | 62 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 2.28e-01 | 1.00e+00 | 1.953 | 1 | 1 | 62 |
GO:0000151 | ubiquitin ligase complex | 2.32e-01 | 1.00e+00 | 1.930 | 1 | 1 | 63 |
GO:0005901 | caveola | 2.32e-01 | 1.00e+00 | 1.930 | 1 | 1 | 63 |
GO:0007059 | chromosome segregation | 2.35e-01 | 1.00e+00 | 1.907 | 1 | 3 | 64 |
GO:0016491 | oxidoreductase activity | 2.38e-01 | 1.00e+00 | 1.885 | 1 | 1 | 65 |
GO:0006469 | negative regulation of protein kinase activity | 2.38e-01 | 1.00e+00 | 1.885 | 1 | 1 | 65 |
GO:0030141 | secretory granule | 2.44e-01 | 1.00e+00 | 1.841 | 1 | 2 | 67 |
GO:0000777 | condensed chromosome kinetochore | 2.48e-01 | 1.00e+00 | 1.820 | 1 | 1 | 68 |
GO:0006338 | chromatin remodeling | 2.48e-01 | 1.00e+00 | 1.820 | 1 | 2 | 68 |
GO:0019221 | cytokine-mediated signaling pathway | 2.49e-01 | 1.00e+00 | 1.061 | 2 | 5 | 230 |
GO:0050790 | regulation of catalytic activity | 2.51e-01 | 1.00e+00 | 1.798 | 1 | 1 | 69 |
GO:0035264 | multicellular organism growth | 2.54e-01 | 1.00e+00 | 1.778 | 1 | 1 | 70 |
GO:0042393 | histone binding | 2.57e-01 | 1.00e+00 | 1.757 | 1 | 1 | 71 |
GO:0001503 | ossification | 2.57e-01 | 1.00e+00 | 1.757 | 1 | 2 | 71 |
GO:0000165 | MAPK cascade | 2.60e-01 | 1.00e+00 | 1.737 | 1 | 2 | 72 |
GO:0030425 | dendrite | 2.64e-01 | 1.00e+00 | 1.000 | 2 | 3 | 240 |
GO:0042826 | histone deacetylase binding | 2.66e-01 | 1.00e+00 | 1.698 | 1 | 1 | 74 |
GO:0051897 | positive regulation of protein kinase B signaling | 2.69e-01 | 1.00e+00 | 1.678 | 1 | 1 | 75 |
GO:0060070 | canonical Wnt signaling pathway | 2.69e-01 | 1.00e+00 | 1.678 | 1 | 2 | 75 |
GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | 2.69e-01 | 1.00e+00 | 1.678 | 1 | 1 | 75 |
GO:0031175 | neuron projection development | 2.69e-01 | 1.00e+00 | 1.678 | 1 | 2 | 75 |
GO:0046474 | glycerophospholipid biosynthetic process | 2.72e-01 | 1.00e+00 | 1.659 | 1 | 2 | 76 |
GO:0006914 | autophagy | 2.75e-01 | 1.00e+00 | 1.640 | 1 | 1 | 77 |
GO:0031902 | late endosome membrane | 2.85e-01 | 1.00e+00 | 1.585 | 1 | 1 | 80 |
GO:0005886 | plasma membrane | 2.85e-01 | 1.00e+00 | 0.246 | 14 | 24 | 2834 |
GO:0007565 | female pregnancy | 2.85e-01 | 1.00e+00 | 1.585 | 1 | 1 | 80 |
GO:0051301 | cell division | 2.88e-01 | 1.00e+00 | 1.567 | 1 | 2 | 81 |
GO:0004842 | ubiquitin-protein transferase activity | 2.89e-01 | 1.00e+00 | 0.907 | 2 | 3 | 256 |
GO:0045177 | apical part of cell | 2.91e-01 | 1.00e+00 | 1.549 | 1 | 1 | 82 |
GO:0001726 | ruffle | 2.91e-01 | 1.00e+00 | 1.549 | 1 | 1 | 82 |
GO:0004713 | protein tyrosine kinase activity | 2.91e-01 | 1.00e+00 | 1.549 | 1 | 1 | 82 |
GO:0030336 | negative regulation of cell migration | 2.93e-01 | 1.00e+00 | 1.532 | 1 | 2 | 83 |
GO:0005929 | cilium | 2.96e-01 | 1.00e+00 | 1.515 | 1 | 2 | 84 |
GO:0005179 | hormone activity | 2.96e-01 | 1.00e+00 | 1.515 | 1 | 1 | 84 |
GO:0047485 | protein N-terminus binding | 3.02e-01 | 1.00e+00 | 1.481 | 1 | 1 | 86 |
GO:0006468 | protein phosphorylation | 3.08e-01 | 1.00e+00 | 0.625 | 3 | 6 | 467 |
GO:0032321 | positive regulation of Rho GTPase activity | 3.08e-01 | 1.00e+00 | 1.448 | 1 | 1 | 88 |
GO:0042593 | glucose homeostasis | 3.11e-01 | 1.00e+00 | 1.431 | 1 | 1 | 89 |
GO:0042384 | cilium assembly | 3.14e-01 | 1.00e+00 | 1.415 | 1 | 2 | 90 |
GO:0005777 | peroxisome | 3.14e-01 | 1.00e+00 | 1.415 | 1 | 1 | 90 |
GO:0000166 | nucleotide binding | 3.14e-01 | 1.00e+00 | 0.820 | 2 | 2 | 272 |
GO:0016337 | single organismal cell-cell adhesion | 3.20e-01 | 1.00e+00 | 1.383 | 1 | 2 | 92 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 3.20e-01 | 1.00e+00 | 1.383 | 1 | 3 | 92 |
GO:0006928 | cellular component movement | 3.20e-01 | 1.00e+00 | 1.383 | 1 | 4 | 92 |
GO:0042470 | melanosome | 3.20e-01 | 1.00e+00 | 1.383 | 1 | 2 | 92 |
GO:0005770 | late endosome | 3.25e-01 | 1.00e+00 | 1.352 | 1 | 1 | 94 |
GO:0001764 | neuron migration | 3.31e-01 | 1.00e+00 | 1.322 | 1 | 2 | 96 |
GO:0030426 | growth cone | 3.34e-01 | 1.00e+00 | 1.307 | 1 | 3 | 97 |
GO:0005524 | ATP binding | 3.34e-01 | 1.00e+00 | 0.311 | 7 | 19 | 1354 |
GO:0005178 | integrin binding | 3.34e-01 | 1.00e+00 | 1.307 | 1 | 1 | 97 |
GO:0019899 | enzyme binding | 3.38e-01 | 1.00e+00 | 0.737 | 2 | 5 | 288 |
GO:0051726 | regulation of cell cycle | 3.48e-01 | 1.00e+00 | 1.235 | 1 | 2 | 102 |
GO:0016567 | protein ubiquitination | 3.55e-01 | 1.00e+00 | 0.683 | 2 | 3 | 299 |
GO:0006200 | ATP catabolic process | 3.61e-01 | 1.00e+00 | 0.664 | 2 | 4 | 303 |
GO:0055085 | transmembrane transport | 3.62e-01 | 1.00e+00 | 0.486 | 3 | 3 | 514 |
GO:0006955 | immune response | 3.64e-01 | 1.00e+00 | 0.654 | 2 | 2 | 305 |
GO:0005938 | cell cortex | 3.67e-01 | 1.00e+00 | 1.139 | 1 | 1 | 109 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 3.69e-01 | 1.00e+00 | 1.126 | 1 | 1 | 110 |
GO:0050900 | leukocyte migration | 3.72e-01 | 1.00e+00 | 1.113 | 1 | 1 | 111 |
GO:0020037 | heme binding | 3.72e-01 | 1.00e+00 | 1.113 | 1 | 1 | 111 |
GO:0004674 | protein serine/threonine kinase activity | 3.74e-01 | 1.00e+00 | 0.622 | 2 | 6 | 312 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.79e-01 | 1.00e+00 | 0.360 | 4 | 9 | 748 |
GO:0005635 | nuclear envelope | 3.85e-01 | 1.00e+00 | 1.049 | 1 | 2 | 116 |
GO:0043524 | negative regulation of neuron apoptotic process | 3.93e-01 | 1.00e+00 | 1.012 | 1 | 1 | 119 |
GO:0007411 | axon guidance | 3.97e-01 | 1.00e+00 | 0.554 | 2 | 3 | 327 |
GO:0032496 | response to lipopolysaccharide | 4.00e-01 | 1.00e+00 | 0.976 | 1 | 1 | 122 |
GO:0008283 | cell proliferation | 4.03e-01 | 1.00e+00 | 0.536 | 2 | 4 | 331 |
GO:0007568 | aging | 4.03e-01 | 1.00e+00 | 0.964 | 1 | 2 | 123 |
GO:0007050 | cell cycle arrest | 4.10e-01 | 1.00e+00 | 0.930 | 1 | 2 | 126 |
GO:0008201 | heparin binding | 4.13e-01 | 1.00e+00 | 0.918 | 1 | 1 | 127 |
GO:0030027 | lamellipodium | 4.20e-01 | 1.00e+00 | 0.885 | 1 | 3 | 130 |
GO:0046983 | protein dimerization activity | 4.23e-01 | 1.00e+00 | 0.874 | 1 | 3 | 131 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 4.27e-01 | 1.00e+00 | 0.852 | 1 | 1 | 133 |
GO:0031982 | vesicle | 4.30e-01 | 1.00e+00 | 0.841 | 1 | 2 | 134 |
GO:0006644 | phospholipid metabolic process | 4.37e-01 | 1.00e+00 | 0.809 | 1 | 3 | 137 |
GO:0016055 | Wnt signaling pathway | 4.46e-01 | 1.00e+00 | 0.767 | 1 | 3 | 141 |
GO:0005911 | cell-cell junction | 4.49e-01 | 1.00e+00 | 0.757 | 1 | 2 | 142 |
GO:0016887 | ATPase activity | 4.53e-01 | 1.00e+00 | 0.737 | 1 | 1 | 144 |
GO:0008083 | growth factor activity | 4.56e-01 | 1.00e+00 | 0.727 | 1 | 1 | 145 |
GO:0005125 | cytokine activity | 4.58e-01 | 1.00e+00 | 0.717 | 1 | 1 | 146 |
GO:0006457 | protein folding | 4.65e-01 | 1.00e+00 | 0.688 | 1 | 3 | 149 |
GO:0006974 | cellular response to DNA damage stimulus | 4.85e-01 | 1.00e+00 | 0.603 | 1 | 3 | 158 |
GO:0046777 | protein autophosphorylation | 4.85e-01 | 1.00e+00 | 0.603 | 1 | 1 | 158 |
GO:0000398 | mRNA splicing, via spliceosome | 5.00e-01 | 1.00e+00 | 0.541 | 1 | 2 | 165 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 5.06e-01 | 1.00e+00 | 0.515 | 1 | 4 | 168 |
GO:0030424 | axon | 5.14e-01 | 1.00e+00 | 0.481 | 1 | 4 | 172 |
GO:0007049 | cell cycle | 5.24e-01 | 1.00e+00 | 0.439 | 1 | 4 | 177 |
GO:0045211 | postsynaptic membrane | 5.24e-01 | 1.00e+00 | 0.439 | 1 | 3 | 177 |
GO:0045892 | negative regulation of transcription, DNA-templated | 5.31e-01 | 1.00e+00 | 0.179 | 2 | 2 | 424 |
GO:0006366 | transcription from RNA polymerase II promoter | 5.32e-01 | 1.00e+00 | 0.176 | 2 | 3 | 425 |
GO:0005764 | lysosome | 5.34e-01 | 1.00e+00 | 0.399 | 1 | 2 | 182 |
GO:0001525 | angiogenesis | 5.68e-01 | 1.00e+00 | 0.263 | 1 | 3 | 200 |
GO:0030168 | platelet activation | 5.77e-01 | 1.00e+00 | 0.227 | 1 | 4 | 205 |
GO:0007596 | blood coagulation | 5.80e-01 | 1.00e+00 | 0.049 | 2 | 5 | 464 |
GO:0001701 | in utero embryonic development | 5.86e-01 | 1.00e+00 | 0.193 | 1 | 2 | 210 |
GO:0004871 | signal transducer activity | 5.97e-01 | 1.00e+00 | 0.152 | 1 | 1 | 216 |
GO:0005765 | lysosomal membrane | 6.00e-01 | 1.00e+00 | 0.139 | 1 | 2 | 218 |
GO:0016874 | ligase activity | 6.10e-01 | 1.00e+00 | 0.100 | 1 | 2 | 224 |
GO:0008380 | RNA splicing | 6.23e-01 | 1.00e+00 | 0.049 | 1 | 5 | 232 |
GO:0005759 | mitochondrial matrix | 6.25e-01 | 1.00e+00 | 0.043 | 1 | 1 | 233 |
GO:0008134 | transcription factor binding | 6.45e-01 | 1.00e+00 | -0.036 | 1 | 5 | 246 |
GO:0006351 | transcription, DNA-templated | 6.58e-01 | 1.00e+00 | -0.138 | 6 | 17 | 1585 |
GO:0005874 | microtubule | 6.62e-01 | 1.00e+00 | -0.104 | 1 | 3 | 258 |
GO:0005102 | receptor binding | 6.76e-01 | 1.00e+00 | -0.159 | 1 | 2 | 268 |
GO:0007283 | spermatogenesis | 6.87e-01 | 1.00e+00 | -0.202 | 1 | 2 | 276 |
GO:0042493 | response to drug | 7.03e-01 | 1.00e+00 | -0.263 | 1 | 2 | 288 |
GO:0006954 | inflammatory response | 7.04e-01 | 1.00e+00 | -0.268 | 1 | 1 | 289 |
GO:0005743 | mitochondrial inner membrane | 7.18e-01 | 1.00e+00 | -0.322 | 1 | 1 | 300 |
GO:0005783 | endoplasmic reticulum | 7.28e-01 | 1.00e+00 | -0.346 | 2 | 6 | 610 |
GO:0005856 | cytoskeleton | 7.30e-01 | 1.00e+00 | -0.374 | 1 | 6 | 311 |
GO:0042803 | protein homodimerization activity | 7.33e-01 | 1.00e+00 | -0.362 | 2 | 4 | 617 |
GO:0035556 | intracellular signal transduction | 7.37e-01 | 1.00e+00 | -0.401 | 1 | 5 | 317 |
GO:0046872 | metal ion binding | 7.42e-01 | 1.00e+00 | -0.288 | 5 | 14 | 1465 |
GO:0030154 | cell differentiation | 7.46e-01 | 1.00e+00 | -0.437 | 1 | 3 | 325 |
GO:0007165 | signal transduction | 7.65e-01 | 1.00e+00 | -0.400 | 3 | 7 | 950 |
GO:0007275 | multicellular organismal development | 7.66e-01 | 1.00e+00 | -0.519 | 1 | 2 | 344 |
GO:0007268 | synaptic transmission | 7.75e-01 | 1.00e+00 | -0.557 | 1 | 1 | 353 |
GO:0030054 | cell junction | 7.77e-01 | 1.00e+00 | -0.569 | 1 | 4 | 356 |
GO:0008285 | negative regulation of cell proliferation | 7.88e-01 | 1.00e+00 | -0.613 | 1 | 3 | 367 |
GO:0007155 | cell adhesion | 8.03e-01 | 1.00e+00 | -0.678 | 1 | 3 | 384 |
GO:0005576 | extracellular region | 8.21e-01 | 1.00e+00 | -0.543 | 3 | 4 | 1049 |
GO:0006508 | proteolysis | 8.23e-01 | 1.00e+00 | -0.773 | 1 | 2 | 410 |
GO:0003677 | DNA binding | 8.25e-01 | 1.00e+00 | -0.493 | 4 | 14 | 1351 |
GO:0006355 | regulation of transcription, DNA-templated | 8.47e-01 | 1.00e+00 | -0.617 | 3 | 10 | 1104 |
GO:0008150 | biological_process | 8.57e-01 | 1.00e+00 | -0.935 | 1 | 3 | 459 |
GO:0055114 | oxidation-reduction process | 8.70e-01 | 1.00e+00 | -1.003 | 1 | 2 | 481 |
GO:0005509 | calcium ion binding | 9.18e-01 | 1.00e+00 | -1.295 | 1 | 4 | 589 |
GO:0005615 | extracellular space | 9.29e-01 | 1.00e+00 | -1.073 | 2 | 3 | 1010 |
GO:0008270 | zinc ion binding | 9.42e-01 | 1.00e+00 | -1.152 | 2 | 7 | 1067 |
GO:0016021 | integral component of membrane | 1.00e+00 | 1.00e+00 | -3.371 | 1 | 4 | 2483 |